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Bilateral asymmetry has emerged as a potential new symptom in persons with Multiple 
Sclerosis (MS) with previous studies having found significant asymmetries in peak 
power output (PPO) during single leg cycling and maximal voluntary contraction 
(MVC) strength. However, asymmetry has only been assessed by testing limbs in an 
independent manner. PURPOSE: The purpose of the current study was to assess 
bilateral asymmetry in the contribution to total power output production in persons with 
MS during double leg cycling. METHODS: Nine volunteers with MS (Females = 4) 
and 6 healthy controls (Females= 3) participated in the current study. An initial GXT 
was performed at a Self-Selected (SS) cadence to obtain VO2max and PPO. Subsequent 
GXTs were individualized to allow participants to exercise at relative exercise 
intensities ranging from 50 to 100% of PPO. Participants performed GXTs at either a 
SS, High (20% >SS), or Low (20% < SS) cadence. The contribution of each limb to 
total power output was assessed via dual power meters. Maximal voluntary isometric 
strength was assessed for the knee extensors of each of the lower limbs.  Walking 
capacity was assessed via the 25ft walk and 6 minute walk tests. Independent t-tests 
were used to assess differences in descriptive characteristics, isometric strength 
asymmetry, and walking capacity. Pearson’s r correlations were performed to determine 
the relationship between physiological variables collected during the GXTs and walking 
capacity. Spearman’s correlation was utilized to assess the relationship between 
Expanded Disability Status Scale (EDSS) score and asymmetry levels. Two-way 




physiological variables collected during the GXTs. Differences in the contribution to 
total power production was assessed using a 3 way mixed factorial ANOVA with 
between (group) and within subject factors (cadence x intensity). RESULTS: No 
significant differences existed between groups for descriptive characteristics (p>0.05). 
No significant differences existed between groups and cadence for physiological 
variables. No significant differences were present for contribution to total power 
production for each limb between groups, cadence, and exercise intensity (p>0.05). 
Significant correlations were found between VO2max, PPO, asymmetry during SS 
GXT, and walking capacity during both FTPs. Significant correlations were found when 
subjects were pooled together and in the MS group alone. Significant correlations were 
found between EDSS score and asymmetry levels.  CONCLUSIONS: The current 
study suggests that exercise intensity may not have an impact on bilateral asymmetry 
during double leg cycling. However, other analysis techniques may provide additional 
insights that may be masked by traditional statistical analysis. The use of development 
of thresholds, such as an asymmetry index of 10%, maybe  more appropriate to use in 




Chapter I: Introduction 
 Multiple Sclerosis (MS) is a chronic neurological disease characterized by the 
demyelination of axons within the central nervous system (CNS) (1, 2). This 
demyelination produces scleroses, or plaques, in the white and gray matter of the brain 
and spinal cord causing the disruption of nerve transmission (1). MS patients often 
suffer from symptoms related to central and peripheral impairments, generally speaking 
central impairments involve disruption in the communication to and from the CNS 
whereas peripheral impairments pertaining to alterations within the muscle itself (3). 
Due to the heterogeneous nature of the disease symptoms often differ greatly between 
individuals.  
 Observations of decrements in both muscle function and performance (as a 
result of central and peripheral impairments) leading to lower exercise tolerance have 
been observed in people with MS (4-8). Previous MS related research has shown lower 
force production, higher levels of muscle spasticity, and a reduction in muscle 
activation due to central impairments (9-11). Peripheral alterations to muscular tissue 
associated with MS can include: reductions in muscle enzyme oxidative capacity, 
slowing of muscular contractile proteins, impairment of the excitation-contraction 
coupling processes, and muscular atrophy (3, 6, 7, 11, 12). The central impairments and 
muscular alterations associated with MS can not only cause a reduction in exercise 
tolerance, but also cause an increase in the perceived difficulty to perform activities of 
daily living leading to a decrease in quality of life of MS (13, 14). 
 In addition to symptoms related to central and peripheral impairments recent 




side of the body is more affected than the other side leading to the development of 
bilateral asymmetry. Bilateral asymmetry has predominately been observed in the lower 
limbs (4-7). This can be especially detrimental as lower limb movements such as 
walking and balance can become compromised, leading to an abnormal walking gait 
and increased likelihood of falls (7, 15, 16). To date only a few studies have been 
specifically designed with the purpose to observe, assesses, and understand bilateral 
asymmetry in people with MS. These studies have shown that bilateral asymmetry is 
present for strength, oxygen uptake, and power output in MS patients (4-8). The 
protocols used to assess bilateral asymmetry have utilized single leg cycling and single 
leg maximal voluntary isometric contractions (MVICs) (4-7). By testing the limbs 
independently it creates a gap in the knowledge regarding how bilateral asymmetry may 
influence natural bipedal exercises and movements. Until recently the technology to test 
both lower limbs simultaneously and quantify each limbs contribution to total power 
output during cycling has not existed. The development of this technology could 
potentially lead to improved methodology for the assessment and understanding of 
bilateral asymmetry. A better understanding of the development, progression, and 
effects of bilateral asymmetry is needed to develop rehabilitation strategies with the 
purpose of minimizing the effects of MS.  
    The presence of bilateral asymmetry in traditional double leg cycling has been 
heavily researched (17). It has been established that a degree of asymmetry exists for 
peak crank torque, work, and force during pedaling (17-21). The consensus from these 
studies suggests that both movement and external workload appear to influence bilateral 




asymmetry between subjects and between the protocols utilized (17). Previous research 
has also examined some potential mechanisms for asymmetry during cycling including 
muscle activation using electromyography (EMG) (22). Although differences in muscle 
activation between legs was not present in both healthy controls and trained cyclists this 
information has not been gathered in a population of individuals with neuromuscular 
limitations such as MS.  
 The use of EMG allows for a non-invasive assessment of muscle activation and 
neural drive (23). An increase in workload is associated with muscle fatigue leading to 
the synchronization of motor units and an increase in muscle activation due to the 
recruitment of additional motor units (23, 24). Previous literature has examined bilateral 
differences in muscle activation during cycling in healthy individuals and found no 
significant differences between limbs (22). However, this has not been examined in 
persons with MS where muscle activation may be impaired due to the inhibition of the 
propagation of action potentials. Additionally, bilateral differences in muscle activation 
have only been assessed while cycling at a preferred cadence. Little is known how the 
manipulation of the number of muscular contractions performed will affect this 
asymmetry while power output remains constant. In theory the increasing or decreasing 
of the number of muscular contractions performed per minute while power output is 
maintained will affect the strain placed on the CNS due to alterations in the number and 
strength of action potentials sent from the soma of the neuron (23). The use of EMG 
may provide insight into the potential mechanisms of bilateral asymmetry, and potential 
compensatory mechanisms that may be present in order to possibly maintain symmetry 




 Therefore, the next step in the assessment of bilateral asymmetry in MS patients 
is to test both lower limbs simultaneously in a natural bipedal movement. Testing in a 
bipedal movement could provide further insight into how the limbs work together if a 
bilateral deficit is present that cannot be observed during single leg movements. The 
development of new technology, double leg cycling could now provide a proper 
modality for assessment of asymmetry in MS patients. In addition, the use of EMG on 
both legs during double leg cycling to assess the levels of muscle activation could 
provide an explanation to the presence of asymmetry.  
Purpose 
 Therefore the purposes of this study were to: 1) investigate whether persons with 
MS exhibit greater bilateral asymmetry in power production contribution during a 
double leg graded exercise test compared to healthy controls, 2) investigate potential 
bilateral differences in muscle activation during double leg cycling in persons with MS, 
3) investigate how exercise intensity and cadence selection affect the physical 
manifestation of bilateral asymmetry in persons with MS.  
Research Questions 
RQ1: Do persons with MS exhibit greater bilateral asymmetry in power production 
contribution during a double leg graded exercise test compared to healthy controls?  
RQ2: Is there a bilateral difference in muscle activation during double leg cycling in 
persons with MS?  
RQ3: Does exercise intensity and cadence selection effect the physical manifestation of 




RQ4: Do persons with MS exhibit greater bilateral asymmetry isometric strength of the 
knee extensors compared to healthy controls? 
Hypotheses 
H1a) Individuals with MS will exhibit greater bilateral differences in power output 
during a double leg cycling graded exercise test compared to healthy controls. 
H10) Individuals with MS will not exhibit greater bilateral differences in power output 
during a double leg cycling graded exercise test compared to healthy controls. 
H2a) There will be a bilateral difference in muscle activation during double leg cycling 
in persons with MS.  
H20) There will not be a bilateral difference in muscle activation during double leg 
cycling in persons with MS.  
H3a) The manipulation of exercise intensity and cadence will have significant effect on 
the physical manifestation of bilateral asymmetry.  
H30) The manipulation of exercise intensity and cadence will not have a significant 
effect on physical manifestation of bilateral asymmetry.  
H4a) Individuals with MS will exhibit greater bilateral asymmetry in isometric strength 
of the knee extensors compared to healthy controls.  
H40) Individuals with MS will not exhibit greater bilateral asymmetry in isometric 
strength of the knee extensors compared to healthy controls.   
Significance of the Study 
 To date, no bilateral asymmetry research in MS patients has assessed both lower 
limbs simultaneously in a bipedal movement. New knowledge in how the lower limbs 




rehabilitation programs to reduce asymmetry and thus reduce functional impairments 
associated with MS. The use of EMG during testing will provide insight to the 
mechanism of muscular asymmetry, and provide knowledge for the treatment and 
correction of asymmetry. Minimizing the effects of bilateral asymmetry is important in 
the maintaining and improvement of exercise capacity and quality of life in MS 
patients.  
Delimitations 
The delimitations of this study included: 
1. Individuals between the ages of 18-65. 
2. Individuals with MS had a physician confirmed diagnosis. 
3. Disability status scale score (EDSS) less than or equal to 6.0.  
4. Individuals with MS were not using prednisone or other steroids and did not have a 
steroid dose for at least 3 months prior to testing. 
5. Individuals without asymmetric orthopedic limitations. 
6. Individuals without metabolic, respiratory or cardiovascular diseases. 
7. Individuals all obtained physician’s clearance for exercise prior to testing. 
Limitations 
The limitations of this study included: 
1. Since testing occured on a series of dates and fatigue is variable and unpredictable in 
persons with MS, initial fatigue in multiple sclerosis individuals may differ slightly 
between testing days. 
2. Combinations of medications for symptom management and disease modification may 




3. The same research team conducted all testing for the duration of this study. 
4. Testing will be performed at the Department of Health and Exercise Science at the 
University of Oklahoma in Norman, Oklahoma. 
5. Subjects will be recruited from the Norman and Oklahoma City areas through the MS 
Center for Excellence at the Oklahoma Medical Research Foundation. 
6. All possible testing sessions occured at the same time of day relative to each subject. 
Assumptions 
The assumptions of this study included: 
1. All participants provided accurate medical information and health history. 
2. All participants were honest when filling out fatigue questionnaires. 
3. All participants followed pre-testing guidelines before coming in for testing. 




1. Bilateral asymmetry: significant differences between the left and right side of the body 
(4).  
2. Body Composition: the total amount and distribution of fat mass and fat-free mass that 
makes up a human body (25).    
3. Dual- Energy X-Ray Absorptiometry (DXA)- uses X-rays at two energy levels and 
works on the principle that, as X-rays pass through body tissues they are attenuated to a 




4. Electromyography (EMG)- the extraction of information from the electrical signal 
generated by the activated muscle (23).  
5. Graded Exercise Test: a protocol designed to elicit VO2max in which workload 
increases at a defined rate until exhaustion is reached (27) 
6. Kin-Com Dynamometer: an electromechanical device used to provide resistance 
during isokinetic and isometric muscular contractions (28). 
7. Kurtzke Expanded Disability Status Scale (EDSS)- incremental scale used to assess 
the level of physical disability associated with multiple sclerosis (29).  
8. Matched Control Subjects: subjects in the control group, which will be matched by 
average age, gender, and physical activity level to MS subjects (4). 
9. Maximal Oxygen Consumption (VO2max)- the maximal amount of oxygen that can 
be utilized by the muscles during a maximal effort cycling test (27) 
10. Multiple Sclerosis: inflammatory degenerative autoimmune disease of the central 
nervous system (2).  
11. Relapsing Remitting: a clinical course of multiple sclerosis characterized by disease 
relapses and stages of either full recovery or a deficit after recovery with no progression 
of disease symptoms during the recovery stages (30).  
12. Quality of Life (QOL): An umbrella term to describe a number of outcomes important 
within an individual’s life (31). 
13. 6-Minute Walk Test (6MW): This is a functional test and used to assess 
cardiopulmonary function and has been used in neurological populations.  Participants 




14. 25-Foot Walk Test (25FW): This is a functional test used to assess an individual’s 
walking ability and leg function based on a timed 25-foot walk.  Gait speed has been 











Chapter II: Review of Literature 
 Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system 
(CNS)  characterized by the development of plaques or sclerosis along the myelin 
sheath of axons resulting in nerve demyelination (34). The detrition of the myelin 
sheath can cause the attenuation or even the inhibition of action potentials. This 
disturbance in the propagation of action potentials along the axon can cause a plethora 
of disabling physical symptoms such as: mobility and coordination issues, optic 
neuritis, fatigue, and pain (2). MS patients can also suffer from cognitive dysfunction 
and mood disorders leading to further reductions in quality of life (35, 36). MS 




Researchers have recently explored a potentially new symptom of MS. It has been 
found that MS patients tend to suffer muscle weakness and decrements in strength and 
cardiovascular performance of their lower limbs (4-8). These decrements are noted to 
be greater in one limb than in the opposite limb (4-8). These disparities can result in 
bilateral asymmetry in musculoskeletal performance. The extent to which asymmetry 
affects individuals with MS and how it impacts function still needs further 
investigation. The purpose of this review is to provide an understanding of the 
pathophysiology of MS, bilateral asymmetry in MS, and the impact of bilateral 
asymmetry on quality of life in MS patients. This will provide support for the proposed 
project related to assessment of asymmetry during cycling in MS patients. Finally a 
summary of pertinent literature on asymmetry during cycling will be presented.   
 
  
Multiple Sclerosis  
Axons of neurons within the CNS are coated in a fatty sheath known as the 
myelin sheath (1, 2). The myelin sheath provides insulation for the axon, and helps 
increase conduction velocity of action potentials down the axon (37). MS causes the 
deterioration of the myelin and the loss of both neuronal axons and myelin producing 
oligodendrocytes (2). The demyelination of the axons causes the development of 
sclerosis, or plaques, in the white matter of the brain and the spinal cord that disrupt 
nerve transmission as well as inhibit the formation of new myelin (38). The attenuation 
or inhibition of nerve transmission can lead to a wide range of debilitating physical 




theories to the cause of MS, but three main schools of thought for the pathophysiology 
of MS have risen: genetic, environmental and infectious agent, and autoimmune.  
Genetic  
 A genetic predisposition has been established for MS through: familial 
aggregation (39), high monozygotic concordance rate (31%) (40). The lifetime 
incidence of MS is 0.1% in a normal population, but this increases to 3% for siblings of 
MS patients (41). The risk of incidence increases to 25% for the twin of an MS patient 
(41). The genes that contribute to MS susceptibility have not yet been identified, but 
efforts have been taken to identify potential risk alleles that may predispose for MS. 
Linkage studies have identified human leukocyte antigen (HLA) alleles as MS risk 
genes (42, 43). The findings of these studies have been interpreted with caution to due 
flaws in the techniques used. However, using association studies, which exam single 
nucleotide polymorphisms on a genome-wide level, Interleukin 2 Receptor Subunit 
Alpha  (IL2Ra), Interleukin 7 Receptor (IL7R), and Lymphocyte Function Associated 
Antigen 3 (LFA-3) genes were newly identified as risk alleles for MS (44). Further 
studies are needed to confirm current genetic findings and to identify new genes.  
Environmental and Infectious Agent  
 The prevalence of MS has been observed to increase with increases in the 
distance from the equator (29). Due to the difficult nature of ecological case-control 
studies it is unclear whether environmental factors elevate the risk of an individual or an 
entire population for the development of MS.  
 Infectious diseases such as Chlamydia pneumonia , human herpes virus-6 




MS. These hypothesis have been based on the isolation of genetic material or proteins 
of microbial agents from MS lesions (45-47). Recently, in post-mortem brain specimens 
from MS patients genes and proteins from EBV associated with both latent form and 
reactivated form of the virus have been identified (47). However, these findings have 
not yet been reproduced by other groups and should be interpreted with caution. Some 
researchers believe the relationships between these infectious agents and MS is merely 
casual and not direct with the infectious agents providing the appropriate cascade for an 
autoimmune reactive response against the CNS (48).  
Autoimmune Response  
 The myelin sheath of neurons not only increase conduction velocity along axons 
but also contributes to the protection and health of the axon (49). The main 
characteristic of MS is the attacking and deterioration of this myelin sheath. It is 
generally well accepted that the pathology of MS begins with a breach in the blood-
brain barrier allowing for the influx of autoimmune agents into the CNS, and initiating 
an inflammatory response (2). One hypothesis suggests that individuals with MS are 
genetically predisposed for the breach in the blood-brain barrier (50). While others 
believe that some forms of systemic infection may cause the up-regulation of adhesion 
molecules on the endothelium of the brain and spinal cord thus allowing autoimmune 
agent to enter the CNS (48). 
 Among the agents that have been suggested to be involved in the inflammatory 
response in the CNS are autoreactive T cells (CD4+ and CD8+). These cells react to 
antigens located in the myelin of the CNS and will result in demyelination (51-53). 




However, an MS patient exhibits an activated phenotype while those from healthy 
individuals appear to have a naïve phenotype (54, 55). T cells believed to be involved in 
the inflammatory response have been suggested to be type 1 helper T cells that produce 
interferon-y which has been shown to mediate inflammatory responses (53). Once the T 
cells enter the CNS, they begin to attack the myelin sheath and begin to create plaques 
or sclerosis at the sites of attack (56). Due to the heterogeneity of MS no distinct pattern 
of sclerosis development has been observed and is considered unpredictable (48).  
 In addition to the development of plaques on the myelin sheath, MS can cause 
axonal injury (57). Pathological changes in the axons can be detected early in the 
disease progression by the accumulation of amyloid precursor protein due to 
inflammation (58). In an attempt to reestablish normal conduction there is an increase in 
sodium entry into the axon, followed by the reversal of the sodium-calcium exchanger, 
which may cause axonal injury or even neuronal degeneration due to the influx of 
calcium (57). Axonal injury continues to increase with the progression of the disease 
with some old lesions having an axonal loss of more than 80% (56). The cumulative 
loss of axons correlates with irreversible disability (48). 
 Remyelination occurs frequently in the plaques of MS patients but is ineffective 
in reestablishing its normal function (2). Remyeliation often occurs in plaques that 
develop early in the disease process but are often restricted to the periphery of inactive 
plaques forming shadow plaques (59). The extent of the repair to the myelin sheath is 
related to survival of oligodendrocytes within the plaques. Often very few 




(60, 61). These cells can re-express developmental genes and produce myelin in 
demyelinated areas.  
Symptoms  
 The symptoms associated with MS vary greatly between patients (1). It is still 
unclear as to how the site of plaques, the number of plaques, and the stage at which the 
plaques are in affect symptoms. However, it is clear that many symptoms impair the 
ability of MS patients to exercise and perform activities of daily living (3, 13, 62). 
Symptoms are typically classified as either being central (alterations within the CNS) or 
peripheral (alterations within peripheral musculature).  
Central Symptoms  
 Reduced central activation has been identified as a primary consequence of MS 
(63). Muscle fatigue has been correlated with an increase in central drive, suggesting 
this as compensatory mechanism to overcome the lack of central activation (63). 
Reorganization of descending axons may be occurring as indicated by the increase in 
central motor drive in the presence of decreased central activation (63). Previous 
research has shown impairments in motor unit firing rates, motor unit activation, and 
slower muscle contraction speeds in MS patients, all of which could have a detrimental 
effect on strength and function (7).  
 Ng et al. 1997 (63) evaluated central motor drive in individuals with MS during 
voluntary dorsiflexion muscle contraction using EMG on the tibialis anterior muscle. It 
was observed that central motor drive was increased in MS patients compared to 
healthy controls during submaximal contractions ranging from 10 to 70% of an 




and the slope of the EMG/force relationship of the MS individuals were highly 
correlated (r = −0.87, P < 0.001). The researchers observed that even the MS 
individuals without any visible weakness (limping) still showed an increased motor 
drive. The findings of this study suggest that central drive alterations are present and 
occur before any physical manifestations are visible.  
 Ng et al. 2004 (9) performed another study to investigate central motor 
impairments in conjunction with peripheral muscle adaptations thought to be a result of 
MS. Central impairment was assessed by having eighteen MS subjects and eighteen 
healthy controls perform a voluntary maximal isometric contraction (MVIC), followed 
by another MVIC with additional electrical stimulation. The central activation ratio was 
determined by dividing the maximal voluntary force divided by the maximal force 
produced with superimposed electrical stimulation. If more force is produced by the 
muscle during electrical stimulation it suggests the presence of central impairments. The 
current study examined the ankle dorsiflexion and found that MS patients showed 32% 
less maximal force production (N) than healthy controls (CON vs. MS: 157 ± 12 vs. 
115 ± 15; p = 0.03). However there was no significant difference between MS patients 
and healthy controls for force produced (N) with the electrical stimulation (CON vs. 
MS: 122.1 ± 11.3 vs. 125.9 ± 12.8; p = 0.82). It was therefore concluded that reductions 
in the central activation ratio within the MS patients was a result of incomplete motor 
unit recruitment.  
 Assessing impairments in central activation is a difficult task due to the 
intertwined nature of the CNS and peripheral nervous system (PNS). Previous research 




a simple test for the assessment of lower extremity motor function in the upper motor 
neurons (64). This test highlight voluntary maximal rate of force production (64). The 
“toe-tap” test requires both motor unit recruitment and rate coding to perform the 
maximal amount of successive rapid toe tapping in 10 seconds (64, 65). It has been 
suggested that the “toe tap” test can give an index of motor production and additionally 
an indirect measure of central drive in clinical populations (65, 66).  
Peripheral Symptoms  
 Although MS is a CNS disease, a number of alterations within the peripheral 
musculature have been observed. Previous research has shown decreases in oxidative 
capacity, decreased oxidative enzyme activity, slowing of muscle contractile properties, 
impaired excitation contraction coupling, and muscle atrophy (3, 7, 12, 67).   
 Sharma et al. (3) evaluated the intramuscular components related to the 
development of peripheral fatigue in twenty eight MS patients and fourteen controls. A 
nine-minute intermittent electrical stimulation protocol of the tibialias anterior was used 
to assess force production, intracellular pH, and phosphocreatine (PCr) levels. They 
observed greater decreases in force (MS vs. CON: 64.8 ± 3.6% of initial vs. 86.1 ± 
2.6% of initial, p < 0.01) PCr (MS vs. CON: declined to 16.2 ± 2.7 vs. 25.3 ± 1.8 
mmol/L; p > 0.01), and pH (MS vs. CON: 6.76 ± 0.07 vs. 6.91 ± 0.05 p > 0.05) in MS 
patients when compared to healthy controls with no significant decreases in the 
amplitude of compound muscle action potentials. This finding indicates that 
neuromuscular transmission was not a limiting factor and fatigue was developed in the 
peripheral musculature. The researchers therefore concluded that both central 




excitation contraction coupling, are related to the development of fatigue in MS 
patients.  
Diagnosis  
 It is estimated that 0.1% of the population in temperate climates suffers from 
MS. With some 250,000 to 350,000 people in the US are diagnosed with MS (2). It is 
considered a disease of young people with median age of diagnosis being 29 years of 
age, and the female/male ratio of diagnosis is roughly 3:1 and may be increasing (1, 68). 
It is the second most common cause of disability in young adults, and it is one of the 
costliest chronic diseases, with total annual costs per affected individual exceeding 
US$50,000 (2007), which is similar to that of congestive heart failure (1, 69, 70) . 50% 
of MS patients require a cane to walk 15 years after the disease onset (2, 71). Currently 
there is no definitive diagnostic test or tool Detection of MS involves the use of several 
diagnostic tools including magnetic resonance imaging, cerebrospinal fluid analysis, 
neurological examination, medical history analysis, evoked potential responses to 
sensory stimulation, and blood tests to rule out diseases with similar symptoms. In order 
to ensure a definitive diagnosis of MS a person must present with: two or more areas of 
demyelination, evidence of lesions in the white matter, increased immunoglobin G 
synthesis in the spinal fluid, and two or more neurological deficits(72).  
Bilateral Asymmetry 
It has been shown that MS can affect the body in an asymmetrical nature, where 
one side of the body is more compromised than the other. (4, 5, 7, 8). Researchers have 
noted differences between lower limbs in both strength and cardiovascular measures (4-




daily living that require bilateral function, balance, or a combination of the two such as 
walking (73). These disparities could also place MS patients at a higher risk for falls 
and further decreasing quality of life (74). Bilateral asymmetry is a relatively new area 
of research in MS patients, with the current state of the research being limited.  
 One of the first studies to observe bilateral asymmetry in an MS patient was a 
case study conducting by White and Dressendorfer in 2005 (8). The case study 
examined bilateral differences in oxygen uptake in one female subject with MS. The 
subject performed a traditional double leg VO2max test followed by two single leg 
VO2max tests. It was found that the during the single leg VO2max test, the right leg 
achieved a VO2max equivalent to 85% of that achieved during the double leg test while 
the left leg only achieved 60% of the double leg test. It was also observed that the 
VO2peak (Right vs. Left: 49.3 vs. 34.7 ml/kg/min), heart rate (Right vs. Left 158 vs 134 
bpm), and pulmonary ventilation (Right vs. Left: 81.5 vs. 55.6 L/min) were 30% lower 
during the single max test for the left leg compared to the right leg. The researchers 
suggested that due to a large cardiopulmonary reserve seen during the single leg test of 
the left leg, performance differences between limbs could be contributed to limitations 
in strength or O2 extraction rather than O2 delivery. It is also noteworthy that the subject 
was a former competitive runner, and still maintained a rigorous exercise program even 
after MS diagnosis. The researchers suggested that due to her training program her right 
limb may have experienced increased strength and O2 extraction as a compensatory 
mechanism to offset limitations in her left limb.  
 Chung et al. 2008 (7) examined differences in functional measurements between 




contractions with a resistive load of 45% of the peak isometric torque for both knee 
extensors and dorsiflexors. No significant differences were observed in the isometric 
asymmetry score for both the control and MS subjects in for knee extensors (CON vs. 
MS: 13.9 ± 12.7 vs. 15.7 ± 11.5%; p = 0.72) and dorsiflexors (CON vs. MS: 8.5 ± 5.3 
vs. 10.1 ± 7.7; p = 0.56). No significant differences were observed in dorsiflexors power 
asymmetry score between groups (CON vs. MS: 14.7 ± 15.4 vs. 16.7 ± 12.1; p = 0.73). 
However, significant differences in the knee extensor asymmetry score was observed 
between the groups with the MS group having a significantly greater asymmetry score 
compared to the control group (CON vs. MS: 9.2 ± 6.9 vs. 21.5 ± 16.2; p = 0.02).  
 A major issue regarding research concerning bilateral asymmetry in MS patients 
is the designation or classifying of the legs for comparison. Most studies have compared 
the legs based on right/left or dominant/non-dominant (7, 9, 75). However, bilateral 
asymmetry is not restricted to weakening the non-dominant side of the body (4). 
Asymmetry also does not affect the same side of the body for every individual. 
Classifying and comparing limbs based on these criteria may skew results and hide the 
presence of asymmetries. It has been recommended to classify and compare limbs using 
“more-affected” and “less-affected” limbs when testing for asymmetries (4). One of the 
first studies to use to classification of limbs was Larson et al. 2013 (4). The researchers 
examined the presence of bilateral asymmetries in MVICs and single-leg incremental 
cycling in eight MS subjects, diagnosed with relapse remitting MS, compared to seven 
healthy controls. It was observed that the MS group possessed significantly greater 
differences between limbs in MVIC compared to the control group (MS vs. CON: 8.34 




significantly greater differences between limbs in peak workload (MS vs. CON: 18.1 ± 
14.0 vs. 0.57 ± 5.1watts; p < 0.01)  and VO2peak (MS vs. CON: 3.1 ± 1.9 vs. 0.83 ± 2.0 
ml/kg/min; p < 0.05) in the MS group compared to the Control group during the single-
leg incremental cycling test to failure. To ensure differences in lower limb performance 
was not due to differences in lean tissue mass, DXA scans revealed no significant 
differences in lean tissue mass between limbs (p > 0.05). To highlight the heterogeneity 
nature of bilateral asymmetry and further justification for the use of the “more-
affected/less-affected” limb classification, it was observed that 4 out of the 8 subjects’ 
significantly weaker limb was their dominant limb.  
 Building upon the observations in bilateral asymmetry in cardiovascular 
performance in MS patients, Larson et al. 2014 (5) performed another study to examine 
endurance performance in lower limbs of eight MS patients, diagnosed with relapse 
remitting MS, and 7 healthy controls. Subjects performed a whole body (double leg) 
oxygen uptake test using a cycle ergometer. Subjects then performed a five minute 
single leg submaximal fixed load cycling test. Fixed workload was set at 20% of the 
peak workload achieved during the whole body oxygen uptake test. It was observed that 
the MS subjects performed significantly more work (KJ) with the less-effected limb 
than the more-effected limb (less-effect vs. more effected: 6.4 ± 1.7 vs. 4.7 ± 2.5 kJ; p = 
0.02), while no significant differences were observed between limbs in the Control 
group (less-effect vs. more effected: 9.2 ± 3.2 vs. 9.1 ± 3.2; p = 0.36). The difference 
between limbs was also significantly greater for work performed in the MS group 




 The research in bilateral asymmetry in MS patients has revealed significant 
asymmetries between lower limbs for strength measurements and cardiovascular 
responses (4-8) All of the previous research has isolated lower limbs and tested them 
independently of each other. However, the modalities tested have been bipedal 
movements in nature. Performing testing using modalities such as single leg cycling 
may not necessarily provide data that can be interpreted and applied to functions that 
require limbs to function simultaneously together. Therefore, future research should 
focus on testing lower limbs with more natural modalities (walking, double leg cycling) 
in order to examine how the more-affect and less-affected limbs work together during 
bipedal movements.  
Effects of Bilateral Asymmetry on Function 
 The full effects of bilateral asymmetry on quality of life and activities of daily 
living are not fully understood yet. However, research has shown that MS patients with 
bilateral asymmetry have slower 25 foot walk times at both brisk and normal paces, 
take more steps during 25 foot walk test, show great amounts of sway during postural 
control tests, and possess asymmetrical hip bone density (7, 76).  
 Chung et al in 2008 (7) observed significantly greater levels of bilateral 
asymmetry in the knee extensors in MS patients (CON vs. MS: 9.2 ± 6.9 vs. 21.5 ± 
16.2; p = 0.02). Postural stability was also tested in this study using two adjacent force 
plates to record ground reaction forces underneath each foot while subjects stood 
quietly for 20s with their eyes directed forward. Data from the force plates was used to 
calculate center of pressure variability (CoPv) in the anteroposterior (AP) and 




observed that MS patients displayed a significantly greater COPv in the AP direction 
compared to controls (7.52 ± 3.02 and 4.33 ± 1.79mm, respectively; p = 0.005  . The 
loading asymmetry score between limbs was significantly greater in MS compared to 
controls (CON vs. MS: 6.0 ± 3.0 vs. 10.5 ± 6.9; p = 0.05). The researchers observed a 
high correlation between limb-loading asymmetry and postural sway in both the AP (r = 
0.62, p = 0.001) and ML (r = .80, p = <0.001) directions suggesting that load 
distribution beneath the feet plays a role in postural control and stability. No 
relationship was observed between limb-loading asymmetry and knee extensor 
asymmetry (p > 0.05) in the MS patients, but a significant association between knee 
extensor power asymmetry and CoPv in the AP direction (r = 0.58, p = <0.01) did exist. 
Although no relationship appeared to exist with bilateral asymmetry in knee extensors 
and asymmetry in limb loading there appears to be a relationship in limb loading and 
postural control, which a relationship did exist with knee extensor asymmetry, it cannot 
be fully concluded that muscle asymmetries do not contribute to asymmetries in limb 
loading. Further research is needed to fully understand the interaction between muscle 
asymmetries, postural control, and limb loading asymmetry.  
 In the same study by Chung et al. in 2008 (7), MS patients performed a 25 foot 
walk test at a normal and brisk pace. It was observed that the MS patients required more 
time (CON vs. MS: 6.8 ± 0.7 vs. 9.0 ± 1.8 seconds; p = <0.001 & 4.8 ± 0.4 vs. 6.6 ± 
1.5; p = <0.001 ) and more steps (CON vs. MS: 12 ± 1 vs 14 ± 2; p = 0.001 & 10 ± 1 vs. 
12 ± 2; p = <0.001)  to walk 35ft at both the normal and brisk paces, respectively, 
compared with controls. It was also observed at a significant relationships existed 




brisk pace (r = 0.61, p = < 0.001) walk times, with the greater the asymmetry the slower 
the times. This finding suggests that power asymmetry in the lower limbs may 
negatively affect gait and walking speed.  
 Larson et al. (4) observed significant bilateral differences in peak VO2  and peak 
workload between legs of MS patients using a single leg graded exercise test. Subjects 
also performed a six minute walk test prior to all testing. It was observed that subjects 
covered significantly less distance when compared to controls (MS vs. CON: 474.3 ± 
93.1 vs. 626.9 ± 94.0 meters; p < 0.05) . It was also observed that a significant 
relationship between six minute walk test performance and leg differences in peak 
workload (r= -0.65, p < 0.05) with larger differences between legs in peak workload 
resulted in less ground covered during the six minute walk test. The researchers 
concluded that bilateral differences could be the reason for a large amount of the 
limitations in functional capacity, but more research is needed to support this 
conclusion.  
Conventional practices for assessing lower-extremity bone mineral density 
(BMD) of only one of the proximal femoral neck of the hip and using this measurement 
to represent the BMD of the contralateral hip due to the negligible differences in BMD 
between dominant and non-dominant or right and left hips (76-80). Due to lower limb 
bilateral asymmetry, Larson et al. 2011 (76) examined the BMD of both of the proximal 
femoral hip in MS patients. The researchers observed the proximal femoral neck of the 
more-affected limb showed lower BMD compared to the proximal femoral neck of the 
less-affected limb. If the conventional method for assessing BMD of the proximal 




of the participants would have been misclassified or experienced undetected bone loss if 
the less-effected limb had been scanned. The researchers suggested that the BMD 
differences observed could be related to atypical bone remodeling associated with low 
or unusual load-bearing status, muscle weakness, and atrophy.  
More research is needed in the area of bilateral asymmetry in MS patients as a 
whole, but more emphasis needs to be placed on understanding the consequences to 
overall health and activities of daily living.  
Assessment of Asymmetry via Double Leg Cycling 
The presence of asymmetry in cycling has been explored with findings showing 
some degree of asymmetry in: force, crank torque, work, and power output (17-21, 81). 
Researches have also examined and suggest that movement speed and external 
workload appear to influence bilateral asymmetry. However, there is a high variability 
of asymmetry indexes (level of asymmetry) between subjects and protocols used for 
evaluation. No definitive protocol has been established to effective evaluation of 
bilateral asymmetry during cycling.  
Carpes et al. in 2007 (82) used six sub-elite competitive cyclists to examine 
asymmetries in crank torque during a 40km time trial (TT). Subjects were asked to 
complete the 40km TT using a self-selected strategy to complete that distance in the 
quickest time possible. The data was divided four stages of equal time according to the 
total time to complete the TT. Comparisons between legs for crank torque were based 
on dominant/non-dominant classification of the legs. Although not statistically 
significant, exercise intensity was higher in stages 1 and 4 compared to stages 2 and 3, 




between exercise intensity and peak crank torque. The researchers observed a 
significantly greater peak crank torque during the 4
th
 stage of the TT when compared to 
the other three stages. A significant reduction in crank torque was observed in stages 2 
and 3 compared to stage 1 and stage 4. No significant differences in crank torque were 
observed between stages 2 and 3. When examining the asymmetry in crank torque 
production as in indicated by AI% [(Dominant leg-Nondominant leg)/Dominant leg) X 
100], an AI% of > 10% was considered asymmetrical. It was observed that during 
stages 2 and 3 an AI% of 13.51±4.17% and 17.28±5.11% respectively and considered 
asymmetrical. However, during stages 1 and 4 no asymmetries in peak crank torque 
were observed. It was also noted that the dominant leg produced significantly greater 
peak torque than the non-dominant leg during stages 2 and 3. Significant levels of 
asymmetry in crank torque were noted in stages 2 and 3 when crank torque was 
significantly lower than stages 1 and 4. During stages 1 and 4 no significant levels of 
asymmetry were observed in accordance with significantly higher levels of crank 
torque. These findings suggest that asymmetry associated with the dominant leg 
changed systematically with crank torque and exercise intensity, with the higher levels 
of crank torque and exercise intensity showed lower levels of asymmetry.  
The influence of pedaling rate on bilateral asymmetry in cycling has been 
examined by several researchers. Daly et al. in 1971 (18) examined how three different 
cadence rates (40, 70, and 100 rpm) performed at resistance setting of 1.6, 2.2, and 3.8 
kilopond on a monarch cycle ergometer would affect bilateral asymmetry. Subjects 
were considered to be recreational cyclist. Legs were classified and compared in two 




which leg applied more force to the pedals. No significant effects for speed or resistance 
changes were shown between conditions when using strength dominance for 
comparison. However, when using leg dominance for comparison it was shown that a 
main effect existed for speed although no directional trend existed. The researchers 
observed that one leg tended to generated more crank torque than the other leg. 
However, no trend in terms of leg dominance seemed to exist when analyzing crank 
torque asymmetry. The findings of the current study should be interpreted with caution; 
the day to day reliability of the index of asymmetry was 0.47.     
 Smak et al. (21) examined whether bilateral asymmetry in cycling changed 
systematically with pedaling rate. Eleven male competitive cyclists were recruited for 
this study and performed five different cycling trials at five different pedaling rates (60, 
75, 90, 105, and 120 rpm) all at 250 watts. Asymmetry was examined by calculating 
differences in average positive power (%AP), average negative power (%AN), and 
average crank power (%AC). Simple linear regressions were used to assess the 
relationships between the subject sample and these measures as well as the individual 
subject and asymmetry measures. For the subject sample only %AN exhibited a 
significant linear relationship with pedaling rate, with asymmetry decreasing as pedal 
rate increased. The dominant leg was observed to contribute significantly greater 
average crank power than the non-dominant leg, but the non-dominant leg contributed 
significantly greater average positive power and average negative power than the 
dominant leg. No significant linear relationships existed for %AP, %AN, and %AC 




pedaling rate with the sample caused different systemic changes in asymmetry with 
pedaling rate.  
The effect of bilateral asymmetry on cycling performance is not fully 
understood yet. A study by Liu et al. in 2012 (83) examined the level of bilateral 
asymmetry in across different age group (Young Children (YC)= 5-7years, Old 
Children (OC)= 8-10years, Adult (AD)= 24-30years) and its effect on cycling 
performance. Participants performed five 15-second pedaling trials at five randomized 
target cadences (40, 60, 80, 100, and 120 rpm). Asymmetry was determined by 
calculating the asymmetry index (AI) used in previous studies using the average angular 
velocity of the ergometer’s crank at 90 and 270 degrees in the crank cycle (90 degrees 
corresponds to the maximum mechanical advantage for pushing with the right leg, and 
270 degrees for the left leg). Cycling performance was measured by calculating root 
mean square error (RMSE) and was an indication of how closely the participant’s 
performance matched the target cadence. Higher RMSE indicated poorer cycling 
performance. Bilateral asymmetry was highest in the YC, followed by the OC, and AD 
groups. It was observed that YC showed significantly higher RMSE than AD at all 
cadences, and had significantly greater RMSE when compared to OC all at cadences 
except for 80 and 120 rpm. The OC group had significantly greater RMSE than AD at 
all cadences except for 40 and 120 rpm. A significant positive correlation between AI 
and RMSE was observed for all cadences. The researchers concluded that higher AI 
was related to poorer cycling performance as indicated by higher RMSE. However, this 
conclusion should be interpreted with caution. No actual performance measures such as: 




measured. Interpretation of performance was based on the ability to sustain a 
preselected rpm for 15 seconds; little evidence exists to show that this test is a valid 
measure of performance.  
In summary the findings associated with the effect of pedaling rate on 
asymmetry and the relation of leg dominance on asymmetry are somewhat mixed. 
However it seems to be clear that an increase in power output results in a decrease in 
bilateral asymmetry. A clear definitive protocol for the determination of bilateral 
asymmetry is still needed. Previous studies have predominately used a series of steady 
state trials to observe asymmetry during cycling with little known how a continuous 
increase in exercise intensity will affect asymmetry. Previous studies have also 
predominately used crank torque to examine asymmetry. Technology now exists to 
examine the power output of each leg simultaneously together to understand each legs 
contribution to total power output. This understanding would make the creation and 
application of exercise programs designed to reduce asymmetry more conceivable as 
most training programs for cyclist are based on power output (watts). Further research is 
still needed on the level of asymmetry present during cycling, with studies showing that 
a range of 5 to 20% (17) may exist in bilateral performance, in cyclist and several 
subcategories of non-cyclist. With many studies using different methods for the 
identification of asymmetry (>10%, AI%, etc.) a valid method is still in need of 
development.   
EMG during Cycling 
It had been speculated that asymmetries seen during cycling could potentially be 




have examined muscle activation during cycling, to the knowledge of the current 
researcher only one study has examined differences between legs in muscle activation. 
To explore this theory Carpes et al. in 2011 (22) examined muscle activation of the 
gastrocnemius, biceps femoris, and vastus lateralis of both legs during both incremental 
and constant load exercise in both cyclist and non-cyclist. Both groups completed an 
incremental exercise test to failure. Gas exchange and muscle activation, via EMG, 
were analyzed according to 40, 60, 80, and 100% of the individual’s maximal power 
output. 60 to 90 minutes following the incremental exercise test subjects completed a 
constant load trial at 70% of the second ventilator threshold observed during the 
incremental exercise test. In both groups muscle activation of the vastus lateralis and 
biceps femoris increased significantly as the exercise intensity increased in both the 
dominant and non-dominant legs. There was no difference in the magnitude of muscle 
activation between the dominant and non-dominant leg in both groups. The similarity 
between legs supports the proposed role of fatigue on bilateral differences. It is 
proposed that in an increase in bilateral output could facilitate excitability and neural 
coupling by inter-hemispheric cortical communication which is known to be a 
mechanism for the reduction of lateral differences (22, 84, 85). However, higher 
variability in the muscle activation was seen in both groups. In the cyclist group high 
variability was noted for the non-dominant leg while no clear influence of leg 
dominance was observed in the non-cyclist group. The variability seen within the 
cyclist group was significantly lower than that of the non-cyclist group and could be 
related to improved muscle synergy seen through long term training resulting in more 




the asymmetries in favor of the dominant or preferred foot seen during cycling are not 
directly related to the magnitude of muscle activation.  
Summary 
MS is a neurodegenerative disease that results in the demyelination of axons in 
the CNS. To date the exact cause of the disease is still unknown, but many promising 
theories exist. Due to the heterogeneity nature of MS patients can suffer from a wide 
variety of symptoms. Recently bilateral asymmetry has been identified as a symptom 
associated with MS. Research is still needed to develop proper methodology for testing 
asymmetry as well as understanding the cause of the asymmetry and the impact it can 
have on the health and well-being of the subject. Most of the current research on 
asymmetry in MS patients test performance measures in the limbs independently, and 
this methodology may not be an accurate depiction of the relationship and functionality 
of the limbs when working together. Cycling presents a potential modality to test for 
asymmetry in the lower limbs while the limbs are working in sync. Using EMG during 
cycling will also help to understand if the cause of the asymmetry, if present, is due to 











CHAPTER III: METHODOLOGY 
 This chapter presents the methodology for this study. Methods include a 
description of the research subjects, research design, data collection procedures, 
instrumentation, and data analyses.  
Sample Size Calculations 
 Based on single leg cycling data from the current research group’s lab and 
previous literature on differences between limbs during double leg cycling (22) an 
effect size of 0.8 was chosen. Using and effect size of 0.8 and an α of 0.05 a total of 10 
subjects were required for each group to achieve a statistical power of 0.8.  
Participants 
 Nine MS patients (MS group) ages 18 to 65 were recruited for the current study. 
Additionally, 6 non-MS patients (Non-MS group) were recruited for the current study. 
The Non-MS group was matched by age, height, weight, and physical activity level 
with the MS group. All participants signed a consent form approved by the University’s 
Institutional Review Board (IRB). Medical history and physical activity levels were 
determined using an approved questionnaire. MS participants were recruited through 
the Oklahoma Medical Research Foundation’s MS Excellence Center, and matched 
Non-MS participants were recruited from the University of Oklahoma as well as the 
Norman and Oklahoma City metro area.  
Inclusion Criteria 





1. Individuals with MS had a physician’s MS diagnosis of the relapsing-remitting 
progression and were free from relapse for the three months prior to testing. A 
relapse is defined as a period of worsening symptoms lasting longer than 24 
hours.  
2. Both the persons with MS and those in the Non-MS group obtained a 
physician’s clearance for all exercise tests included in the study prior to testing.  
3. Individuals with MS had an Expanded Disability Status Scale (EDSS) score of 
6.0 or less (minimal to moderate disability—may need intermittent or unilateral 
aid to walk 100m).  
4. Individuals on the medication prednisone or who have had a steroid dose less 
than 3 months prior to testing were excluded.  
5. Individuals with any past lower limb orthopedic asymmetries (hip replacement, 
knee surgery, etc.) or other significant lower limb bilateral asymmetries were 
excluded from participation.  
Exclusion Criteria 
Subjects with the following characteristics were not included in the study: 
1. Individuals with orthopedic injuries that would create asymmetry. 
2. Individuals with metabolic, cardiovascular, or respiratory diseases. 
3. Individuals with multiple sclerosis who are not relapsing remitting and have an 
EDSS score greater than 6.0. 
4. Individuals with multiple sclerosis who have experienced a relapse sooner than 
3 months prior to testing.  





 This study utilized a mixed factorial design. Participants were familiarized with 
all equipment and testing protocol prior to testing. Participants performed a graded 
exercise test (GXT) to task failure at a self-selected cadence. Participants then 
performed three additional GXTs, wearing EMG electrodes, with stages that 
corresponded to 50, 60, 70, 80, 90, and 100% of the peak power output achieved during 
the GXT. Each of the three individualized GXTs was performed at a randomly chosen 
cadence that corresponded to either: self-selected cadence, 20% greater than self-
selected cadence (high), and 20% lower than self-selected cadence (low). Additionally, 
participants performed a series of maximal voluntary isometric contractions (MVCs) to 
assess isometric muscular strength. Functional capacity was assessed via the 6 minute 
walk test and the 25 foot walk test. A rest period of at least 48 hours between testing for 














Table 1. Visit Protocol Outline 
Protocol Time 
Visit 1 1. Informed Consent 
2. Medical History Questionnaire  
3. PAR-Q  
4. Symptomatic Fatigue assessment  
5. DEXA Scan  
6. Graded Exercise Test familiarization  
7. Functional Assessment 
familiarization  
8. Maximal Voluntary Isometric 
Contraction Familiarization  
Approximate Time: 120 
minutes 
Visit 2 1. Graded Exercise Test (self-selected 
cadence)  
2. Verification Test  
Approximate Time: 60 
minutes 
Visit 3 1. Individualized Graded Exercise Test 
(cadence randomly assigned) 
Approximate Time: 60 
minutes  
Visit 4 1. Individualized Graded Exercise Test 
(cadence randomly assigned) 
Approximate Time: 60 
minutes 
Visit 5  1. Individualized Graded Exercise Test 
(cadence randomly assigned) 
Approximate Time: 60 
minutes 
Visit 6 1. Maximal Voluntary Isometric Contraction 
Familiarization 
2. Functional Assessment (6 minute walk and 
25 foot walk) 




  Testing was performed at approximately the same time of day throughout the 
study relative to each subject’s first visit. Subjects were asked to abstain from alcohol, 
caffeine, exercise and smoking for 12 hours prior to each visit and consumed a light 
meal 2-3 hours prior to testing. Hydration status was assessed using a refractometer 
(model CLX-1, VEE GEE Scientific Inc., Kirkland, WA) to determine urine specific 
gravity (USG) prior to all exercise tests using. A USG value of no greater than 1.028 
was required before testing can be commenced. If a USG greater than 1.028 was 





Symptomatic Fatigue Assessment 
 Each individual with MS was asked to keep an hourly fatigue diary everyday on 
and between testing sessions and filled out a questionnaire on test days in order to 
determine daily symptomatic fatigue. A specific fatigue decision tree was used in order 
to assess if changes in fatigue are significant enough to reschedule testing. If changes in 
symptomatic fatigue were substantial between testing days (changes of 10 or more 
points on the MFIS and/or persistent low energy levels for multiple days based on the 
RFD), the subject was asked to return to the lab on another day for testing. 
Modified Fatigue Impact Scale (MFIS) 
The MFIS is a 21-item questionnaire using a summated rating Likert scale that 
examines the impact of fatigue on everyday life (87). This questionnaire measures 
physical, social, and cognitive aspects of symptomatic fatigue and allows for the 
calculation of a global score which was used in fatigue evaluation (88).  
Rochester Fatigue Diary  
Rochester fatigue diary (RFD) was filled out for everyday of participation in the 
study including non-testing days. The RFD allows the subject to rate fatigue on a visual 
analog scale for every hour of the day (89). This scale is especially advantageous 
because it specifically assesses reduced energy levels. Past research has shown that 
subjects are better able to assess energy levels over short periods of time than more 
complex aspects of fatigue over longer time periods (89). Fatigue levels between visits 




Maximal Voluntary Isometric Contractions  
The maximal voluntary isometric contraction (MVC) of the knee extensor 
muscles were assessed using a dynometer (KinCom model: KC125AP, Isokinetic 
International, East Ridge, TN 37412). Subjects were seated with hip and knee angle set 
at 70°. Participants were asked to perform a series of warmup isometric contractions at 
submaximal intensities with 2 to 3 minutes of rest between contractions. Following the 
warmup, participants performed 3 MVICs lasting 3 seconds each with 3 minutes of rest 
between contractions. Both legs were assessed, and the order was randomly selected.  
Strength Asymmetry Score  
 Strength asymmetry scores were determined for power as:  
𝑆𝑡𝑟𝑒𝑛𝑔𝑡ℎ 𝑎𝑠𝑦𝑚𝑚𝑒𝑡𝑟𝑦 𝑠𝑐𝑜𝑟𝑒 =  [1 − (
𝑃𝑜𝑤𝑒𝑟 𝑜𝑓 𝑊𝑒𝑎𝑘𝑒𝑟 𝐿𝑖𝑚𝑏
𝑃𝑜𝑤𝑒𝑟 𝑜𝑓 𝑆𝑡𝑟𝑜𝑛𝑔𝑒𝑟 𝐿𝑖𝑚𝑏
)] 100  
where the strength ratio was the value for the weaker limb divided by the value for the 
stronger limb. Zero percent asymmetry indicated even distribution of power across 
limbs, and 100% indicated maximal asymmetry (7).  
25-Foot Walk Test  
 The 25-foot walk test has been an assessment tool used by researchers and 
clinicians to assess disease progression in MS patients (13, 41, 78, 90), and has been 
included in the Multiple Sclerosis Functional Composite score (91). Testing procedure 
involved participants starting in a standardized standing position, and walking 25-foot 
as quickly as possible. Researchers utilized multiple timers that began when the 
participants initiate movement from the starting position, and end when the participant 




standardized instructions: “I’d like you to walk 25 feet as quickly as possible, but 
safely. Do not slow down until you after you have passed the finish-line. Ready? Go.”  
Six Minute Walk Test  
 The six minute walk test (6MWT) has been identified as a valid assessment of 
an individual’s functional capacity, accurately predicting morbidity and mortality, and 
better reflects activities of daily living compared to previously used assessments (92). 
Testing was conducted on a 60 meter marked course. During testing participants were 
instructed to cover the largest distance they could during the 6 minutes of allotted time. 
Participants walked alone during testing. The total distance covered during testing by 
each participant will be measured.   
Body Composition 
 Total body and lower-limb composition was assessed using a whole body Lunar 
dual-energy x-ray absorptiometry (DXA) scanner (with software version 13.60.033, 
GE-Lunar Prodigy Advanced, Madison, WI). This test was used to compare body 
composition of the lower-limbs (93). Daily calibration was performed using a 
manufacturer produced phantom of a known density providing scan accuracy. Pre-Scan 
calibration quality assurance indicated a low correlation of variance (<0.2%). Subjects 
were asked to wear clothing without any metal pieces (ex. Zippers, buttons) and all 
attenuating materials and shoes were removed before testing. Subjects were positioned 
in the center of the DXA table in the supine position using standardized positioning; the 
arms close the sides of the body and with legs secured by Velcro straps. Subjects too 
wide for the scanning bed had each side of the body tested separately and composition 




Assessment of the lower legs was used to determine any significant differences in lean 
mass of the legs between groups. From the full body scans separate regions of interest 
were made of the lower-legs, using the tibiofemoral joint of the knee and subtalar joint 
of the ankle as landmarks. The region of interest for each lower leg was quality checked 
by two separate researchers to ensure accuracy. Subjects had their hydration tested prior 
to the DXA scan. If a female subject was premenopausal, a urinary pregnancy test (SA 
Scientific Ltd 087525, Northalke, IL) was conducted prior the DXA scan. 
Graded Exercise Test 
A magnetically braked cycle ergometer (Sport Excalibur, Lode; B.V. Medical 
Technology, Groningen, The Netherlands) along with a metabolic cart (True One 2400, 
Parvo Medics, Sandy, UT) was utilized to perform a graded exercise test (GXT) to 
determine VO2max and peak power output. Subjects were instructed to abstain from 
exercise and caffeine twelve hr prior to testing and to fast three to four hr prior to 
testing. A urine sample was obtained to determine urine specific gravity using a 
refractometer (model CLX-1, VEE GEE Scientific Inc., Kirkland, WA). Subjects were 
required to have a urine specific gravity between 1.004 and 1.028 to be considered 
adequately hydrated to perform the GXT. In the instance a participant was not 
adequately hydrated they were instructed to consume a glass of water and rest for 30 
minutes before collecting a second sample. If at that time they were still under hydrated 
they were rescheduled for a subsequent day. A resting fingertip capillary blood sample 
was collected to determine whole blood lactate concentration prior to testing using a 
commercial lactate meter (Lactate Plus, Nova Biomedical, Waltham, MA) that was 




mM) (Lactate Plus, Lac Control Level 2, 4.0-5.4 mM) before each use. Subjects were 
instructed to pedal at a cadence (RPM) that was comfortable and they felt they could 
maintain for an extended period of time. Following a one minute rest period and a five 
minute warm up at 50 watts (W), the GXT was initiated at a work rate (W) equal to that 
of the subject’s body weight in kilograms (kgs) and increased in W by 50% of the 
subject’s body weight every three minutes until the participant reaches their limit of 
exercise tolerance indicated by a pedal rate dropping more than 10 RPM from their self-
selected cadence. At the end of each of the three-minute stages blood lactate and rating 
of perceived exertion (RPE) based on the Borg Scale were measured (94). Metabolic 
and ventilatory data were continuously measured and averaged over 30 second 
intervals. Heart rate (HR) was measured via a telemetric heart rate monitor (Polar T31, 
Polar Electro Inc., NY, USA).  
VO2max Verification  
 Participants were given 20 minutes of rest following the completion of the initial 
graded exercise test before beginning the Verification protocol (95). Using the peak 
power output (PPO) obtained during the initial GXT, participants performed a 
multistage warm-up that consisted of 2 minutes at 50% of PPO followed by 1 minute at 
70% of PPO. The workload then increased to 105% of PPO and participants were 
instructed to maintain their self-selected cadence for as long as possible. When cadence 
decreased by greater than 10 rpm exercise was terminated. This protocol allowed for not 
allow the verification of VO2max, but also the verification that the PPO assessed during 




Individualized Graded Exercise Tests  
 Using the data collected from the initial GXT, subsequent GXTs were designed 
in a manner that allowed for participants to exercise at specific relative exercise 
intensities. Individualized GXTs consisted of a three minute warm-up at 25% of the 
PPO determined from the initial GXT and verification protocol. Following the warm-
up, the work rate increased to 50% of the individuals PPO and increased by 10% every 
stage. Stages were three minutes in length, and at the end of each stage blood lactate 
and rating of perceived exertion (RPE) based on the Borg Scale were measured (94). 
Each individualized GXT was performed at a different cadence, and was randomly 
assigned prior to each visit. During the Self-Selected cadence condition subjects were 
instructed to pedal at the same cadence as during the initial GXT and verification 
protocol. During the High cadence condition participants were instructed to pedal at an 
rpm corresponding to 20% greater than the rpm during the Self-Selected condition. 
During the Low cadence condition participants were instructed to pedal at an rpm 
corresponding to 20% less than the rpm during the Self-Selected condition. Exercise 
termination was indicated by a pedal rate dropping more than 10 rpm from the 
predetermined rpm. Time to exhaustion (TTE) represented the amount of time exercise, 
not including warm-up, prior to exercise being terminated. The power output, in watts, 
reached (W @ TF) and the percentage of PPO (%PPO) achieved at task failure will be 
recorded. The percent difference in the asymmetry in contribution to total power 
production (% Asym) will be calculated for each exercise intensity. The following 
equation will be used in assessing % Asym: |% Contribution of the Left Leg - % 




Surface Electromyography (EMG) 
 During all GXTs bipolar surface EMG (BIOPAC
®
 Systems, Inc., Goletta, CA) 
signals was collected from the left and right vastus lateralus and vastus medialus. 
Surface electrodes were positioned on the skin after careful shaving and cleaning of the 
area with an abrasive cleaner and alcohol to reduce the skin impedance. The electrodes 
were placed in a bipolar configuration over the belly of the muscles, parallel with the 
orientation of the muscle fibers and taped to the skin using micropore tape to minimize 
movement artifact. A reference electrode was placed over the skin of the acromion to 
serve as a neutral site. Raw EMG signals were smoothed with a fourth-order band-pass 
digital filter at 10-500 Hz. After full-wave rectification and offset correction, the onset 
and offset of EMG activity were determined by the signal’s variation two standard 
deviations above the baseline value recorded between each EMG burst (96). The 
average root-mean-square value of three pedal strokes was calculated every 20 seconds 
of each stage, excluding the first and last 10 seconds of each stage.(97, 98). Offline 
analyses of EMG signals were developed with custom-written scripts (MATLAB 7.0, 
Mathworks Inc., Novi, MI, USA). For each participant and each muscle, the calculated 
root-mean-square values were plotted against time for each stage. The highest W that 
resulted in a non-significant slope coefficient for the EMG amplitude, as indicated by 
the root-mean-square, versus time relationship was determined to be the neuromuscular 
fatigue threshold (99).  
Data Management and Analysis 
 All required documents were stored in a locked filing cabinet in the Human 






 spreadsheet on a password protected personal computer in 
the Human Performance Lab at the University of Oklahoma.  
Statistical Analysis 
 All analyses was performed using IBM SPSS Statistics (version 22.0; IBM 
Corp., Armonk, N.Y., USA). Descriptive statistics were used to summarize the 
demographic data. Independent samples t-test analysis using difference scores (|left leg 
– right leg|) were utilized to assess differences in lower limb body composition. Due to 
the complex nature of both MS and bipedal movements, difference scores were also 
utilized for analyses to detect absolute differences without an indication of the direction 
of the difference. The study’s current methodology of testing did not allow for the 
classification of limbs either as: left leg and right leg or strong leg and weak leg. 
Therefore, independent samples t-test were used to assess isometric strength asymmetry 
and walking capacity during functional performance tests. Intra class correlation 
coefficients (ICCs) were calculated for VO2max and max heart rate to assess between 
visit reliability. Pearson’s r correlations were performed to determine the relationship 
between physiological variables collected during the GXTs and walking capacity during 
functional performance tests. Spearman’s correlation was ran to evaluate the 
relationships between EDSS scores and walking capacity. Two-way repeated measures 
ANOVA were used to detect group x cadence interactions for physiological variables 
collected during the GXTs. Differences in the contribution to total power production 
was assessed using a 3 way mixed factorial ANOVA with between (group) and within 
subject factors (cadence x intensity). When significant interactions and effects were 




within-group differences were located. An alpha level of 0.05 was the criteria to 
establish statistically significant differences. Cohen’s d effect sizes were analyzed when 
appropriate. A value of < 0.19 was considered trivial, 0.20-0.49 was considered a weak 
effect, a value of 0.50-0.79 was considered a moderate effect, and a value of > 0.80 was 
considered a strong effect (100). Effect sizes for ANOVA were analyzed when 
appropriate using eta-squared (η
2
). A value of 0.02 was considered small effect, .13 a 














Chapter IV: Results & Discussion  
Results  
 The results have been divided into two sections. The first section will present the 
statistical analysis of group data. Due to the heterogeneous nature of MS, clinical and 
performance decrements can be masked when examining group averages. Therefore, a 
second section has been added to present individual data.   
Descriptive Data  
 A total of eighteen subjects were consented to participate in the current study. 
There were twelve individuals with a physician’s confirmed diagnosis of MS (MS 
Group) and six individuals without MS (Non-MS). However, three individuals from the 
MS group dropped out of the study due to: time commitment issues, discomfort in the 
knee while cycling, and discomfort in the ankle while cycling. Therefore, fifteen 
individuals completed the study and were included in data analysis. Five males and four 
females (n = 9) were included in the MS group and three males and three females (n = 
6) were included in the Non-MS group. Descriptive and anthropometric data for both 
groups are listed in Table 2.  There were no significant between group differences (p > 
0.05) for all descriptive and anthropometric variables.   All participants in the MS group 
possessed a physician’s diagnosis of relapse remitting MS.  The Expanded Disability 
Status Scale (EDSS) score of 2.0 ± 2.04 indicates a minimal impairment in a 
neurological category. Rochester Fatigue Diaries and Modified Fatigue Impact Scale 
were assessed and analyzed prior to each testing session to ensure similar levels of 





Table 2. Participant Characteristics 
Variable 
MS 
n = 9  
Non-MS 
n = 6 p 
Age (yrs) 46.7 ± 12.4 45.5 ± 8.96 0.84 
Height (cm) 174 ± 4.66 174 ± 10.4 0.95 
Body Mass (kg) 94.2 ± 17.0 80.1 ± 6.17 0.07 
Body Mass Index (kg/m
2
) 30.9 ± 5.79 26.7 ± 3.96 0.14 
Body Fat (%) 42.6 ± 7.91 32.8 ± 14.2 0.10 
Lean Mass (kg) 50.6 ± 68.9 51.8 ± 94.2  0.77 
Fat Mass (kg) 38.5 ± 12.0 25.8 ± 11.9  0.07 
Physical Activity (min/wk) 206.7 ± 180.3 260 ± 129.6 0.55 
VO2max (ml/kg/min) 22.4 ± 8.58 27.9 ± 10.8  0.28 
Max Heart Rate (bpm) 151.8 ± 27.0 161.4 ± 24.8 0.48 
EDSS 2.0 ± 2.04 N/A N/A 
Data are mean ± SD.  EDSS, expanded disability status scale.  *p < 0.05 represents a 
statistically significant difference across group means. 
  
 Lower-leg composition data is presented in Table 4 with gain score analysis. 
Results of the independent t-test indicated no significant differences between groups (p 
> 0.05) for lean mass, fat mass, and fat percentage of the lower leg.  
Table 3. Gain Scores for Lean and Fat Mass of the Lower Legs 
 
Variable MS Δ Non-MS Δ p d 
Lean Mass (kg) 0.13 ± 0.20 0.22 ± 0.15 0.37 0.51 
Fat Mass (kg) 0.08 ± 0.11 0.13 ± 0.55 0.39 1.56 
Lower-Leg Fat (%) 0.00 ± 0.00 0.02 ± 0.041 0.23 5.86 
Data are mean ± SD. Cohen’s d = effects sizes. *p < 0.05 represents a statistically 





Test Reliability  
 All GXT visits were scheduled near the same time of each day to ensure 
consistency across visits. Intra class correlation coefficients (ICCs) were calculated for 
VO2max and max heart rate between the initial GXT and the 3 subsequent GXTs to 
ensure maximal effort was given during each trial. ICCs are summarized in Table 4.  
Both groups demonstrated strong between visit reliability for both measures indicating 
similar levels of effort were provided by the subjects for each test.  
Table 4. Between-visit reliability of VO2max and Max Heart Rate 
 VO2max Max Heart Rate 
Group ICC CI ICC CI 
MS 0.99 0.98 to 0.99 0.99 0.97 to 0.99 
Non-MS 0.99 0.98 to 0.99 0.98 0.93 to 0.99 
ICC: intraclass correlation; CI: 95% confidence limit.  
Graded Exercise Tests  
 Physiological data collected from the three GXT conditions is presented in 
Table 5. The asymmetry collection and analysis software was not used during the initial 
GXT since the stages and work rates did not correspond to relative exercise intensities 
for each individual. Due to this no asymmetry data from the initial GXT is presented.  
Results of the two-way repeated measures ANOVA indicated no significant group x 
cadence interaction for TTE, W @ TF, %PPO, % Asym. However, a significant group 
effect for TTE (F = 6.11, p = 0.028, η
2 
= 0.23) was present. Post-hoc analysis indicated 
that the MS group had a significantly lower TTE (mean ± SD: MS vs. Non-MS = 670.4 




Figure 1 displays the average asymmetry between the lower limbs as a contribution to 
total power output during the 3 different cadence conditions (self-selected, high, and 
low).   
Table 5. Physiological Data During GXTs 
 
Condition Group TTE (secs) W @ TF % PPO % Asym Δ [La] 
Self-
Selected 
MS 729±194 117.2±50.4 81.1±11.0 31.7±51.3 6.23±3.20 
Non-MS 889±129 151.2±65.5 88.3±9.83 4.06±2.98 6.50±3.34 
d 0.97 0.58 0.69 0.76 0.08 
High 
MS 564±225 103.9±49.9 71.1±16.2 31.5±38.9 6.25±3.66 
Non-MS 847±217 147.0±60.9 88.3±9.83 4.06±2.98 7.68±4.13 
d 1.28 0.47 1.28 0.70 0.37 
Low 
MS 716±134 116.1±42.0 83.3±7.01 23.4±38.9 5.49±3.20 
Non-MS 870±126 147.8±64.4 88.3±9.83 3.26±1.84 6.37±4.47 
d 1.18 0.58 0.59 0.73 0.22 
Data are mean ± SD. Cohen’s d: effect sizes; TTE: Time to Exhaustion; W @ TF: Watts 
at Task Failure; % PPO: Percent of Peak Power Output; % Asym: Percent difference 









Figure 1. Average Lower Leg Asymmetry in Contribution to Power Production 
 
Data are presented as mean ± SE. *p < 0.05 represents a statistically significant 
difference. 
 
 Absolute differences in the contribution to total power production at 50, 60, and 
70% of PPO are described in Table 6 and illustrated in Figure 2. These submaximal 
intensities represent the intensities that all subjects were able to complete before task 
failure. A 3 way mixed factorial ANOVA with between and within subject factors 
revealed no statistically significant group x cadence x intensity interaction (F = 0.211, p 
= 0.925, η
2 
= 0.95). No two way interactions were present (p>0.05). No significant main 





























Table 6. Percent Difference in Contribution to Power Production at 50, 60, and 
70% Peak Power Output 
Condition Group 50 % PPO 60% PPO 70% PPO 
Self-Selected 
MS 16.7 ± 17.1 13.9 ± 15.3 12.4 ± 12.1 
Non-MS 6.26 ± 5.37 5.21 ± 4.08 3.63 ± 3.93 
d 0.82 0.78 0.97 
High 
MS 17.2 ± 15.3 14.6 ± 11.6 13.4 ± 12.0 
Non-MS 6.94 ± 3.57 4.70 ± 4.47 3.59 ± 2.58 
d 0.92 1.13 1.13 
Low 
MS 13.7 ± 13.1 9.90 ± 10.9 8.41 ± 9.40 
Non-MS 5.10 ± 2.99 3.13 ± 2.89 2.91 ± 3.07 
d 0.91 0.85 0.79 
Data are mean ± SD. d: effect sizes; 50 % PPO: 50 percent of peak power output; 60 % 
PPO: 60 percent of peak power output; 70 % PPO: 70 percent of peak power output. *p 
< 0.05 represents a statistically significant difference between groups. †p < 0.05 
represents a statistically significant difference from High. ǂp < 0.05 represents a 














Figure 2. Percent Difference in Contribution to Power Production at 50, 60, and 
70% Peak Power Output
 
Data are mean ± SE. 50%: 50 percent of peak power output; 60%: 60 percent of peak 
power output; 70%: 70 percent of peak power output. *p < 0.05 represents a statistically 
significant difference between groups. †p < 0.05 represents a statistically significant 
difference from High. ǂp < 0.05 represents a statistically significant difference from 
Low.  
 
Maximal Voluntary Contractions  
 The group and individual isometric strength asymmetry results are illustrated in 
Figure 3. Independent t-tests indicated there was no significant differences between 
groups for the strength asymmetry score (mean ± SD: MS group vs. Non-MS group = 
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Figure 3. Isometric Strength Asymmetry 
 
Data are presented as mean ± SE. *p < 0.05 represents a statistically significant 
difference. 
 
Functional Performance Tests  
 The group and individual results of the functional performance tests are 
presented in Figures 4 and 5. Independent t-tests indicated no statistically significant 
differences between groups for either the 25WT (mean ± SD: MS group vs. Non-MS 
group = 6.37 ± 4.44 vs. 4.01 ± 0.64, p = 0.23, d = 0.75) or 6MWT (mean ± SD: MS 





































Figure 4. 25WT Performance 
 
Data are presented as mean ± SE. *p < 0.05 represents a statistically significant 
difference  
 
Figure 5. 6MWT Performance 
 










































MS Group  Non-MS Group  





Figure 6. Correlation between Physiological Variables and 25WT Performance in 
Both Groups  (n = 15) 
 
6a - VO2max  
 
6b - Peak Power Output 
 
6c – Self Selected Asymmetry   
 












































r = -0.61* 
r = -0.64* 




Figure 7. Correlation Coefficients between Physiological variables and 6MWT 
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7c- Self Selected Asymmetry  
r = 0.76* 
r = 0.79* 




Pearson’s correlations were measured to assess the relationship between 
functional performance tests, 25WT and 6MWT, and the physiological variables 
assessed as such: strength asymmetry score, VO2max, PPO, and Asymmetry during the 
Self-Selected GXT (Asym. Self-Selected). The Asymmetry during the Self-Selected 
GXT was the only asymmetry condition correlated to walking capacity assessed via the 
functional performance variables since these tests were performed at a self-selected 
speed.  The results for all 15 pooled subjects are presented in Table 8. There was a 
significant correlation between VO2max, PPO, and Asym. Self-Selected for both the 










































































































































































































































































































































































































































































































Groups were separated to investigate the relationships present in each group. In 
the MS group (Table 8) significant correlations were present between 25WT and 
VO2max (r = 0.75 and p = 0.006), PPO (r = 0.82 and p = 0.006), and Asym. Self-
Selected (r = 0.91 and p = <0.001). Significant correlations were also present between 
6MWT and VO2max (r = 0.87 and p = 0.002), PPO (r = 0.87 and p = 0.002), and Asym. 
Self-Selected (r = 0.82 and p = 0.006). In the Non-MS group (Table 9) there was only a 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Additionally, Pearson’s correlations were measured to assess the relationship 
between EDSS score and the percent difference between the lower limbs in contribution 
to total power output during the Self-Selected, High, and Low cadence conditions in the 
MS group. Results are described in Table 10, and displayed in Figure 8. A significant 
correlation was present between EDSS score and percent asymmetry in the Self-
Selected (r = 0.78 and p = 0.01), High (r = 0.839 and p = 0.004), and Low (r = 0.78 and 






































































































































































































































































































































































































































































































Figure 8. Correlation Coefficients between Expanded Disability Status Scale Score 
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Expanded Disability Status Scale 
















Expanded Disability Status Scale 
Figure 8c. Low Cadence 
r = 0.79* 
r = 0.82* 





 Due to issues encountered during data collection, a sufficient sample size was 
not able to be obtained to perform the original analysis intended for the EMG data. 
However, the RMS amplitude across a relative exercise intensity was examined as a 
percentage of the max RMS amplitude obtained during the test. The percent difference 
between the lower limbs for the percentage of max RMS reached during each exercise 
intensity was calculated and displayed in Figures 9, 10, and 11. A one way repeated 
measures ANOVA was performed to detect any significant difference between exercise 
intensities within each cadence condition. No significant differences were present 
between intensities within each condition (p>0.05). The absolute value of the 
normalized RMS amplitude is presented in Table 12. Two-way repeated measures 
ANOVA were used to limb x exercise intensity interactions. No significant differences 
were present (p>0.05). Additionally, the average RMS amplitude for each leg during 
each exercise intensity was plotted against time. Two-way repeated measures ANOVA 
were used to limb x exercise intensity interactions. Data is presented in Table 13. No 








Table 11. Percent Difference between Lower Limbs in Percentage of Max RMS 
Reached for 50, 60, and 70% Peak Power Output 
Condition 50 % PPO 60% PPO 70% PPO 
Self-Selected 2.53 ± 3.79 0.12 ± 0.02 3.97 ± 5.41 
High 5.43 ± 6.29 5.54 ± 4.61 2.38 ± 6.08 
Low 7.50 ± 6.75 6.76 ± 9.25 2.95 ± 9.87 
50%: 50 percent of peak power output; 60%: 60 percent of peak power output;        
70%: 70 percent of peak power output. 
 
Figure 9. RMS Amplitude during Self-Selected Cadence 
 
Data are presented as mean ± SE. 50%: 50 percent of peak power output; 60%: 60 
percent of peak power output; 70%: 70 percent of peak power output. *p < 0.05 



































Figure 10. RMS Amplitude during High Cadence 
 
Data are presented as mean ± SE. 50%: 50 percent of peak power output; 60%: 60 
percent of peak power output; 70%: 70 percent of peak power output. *p < 0.05 
represents a statistically significant difference 
 
Figure 11. RMS Amplitude during Low Cadence 
 
Data are presented as mean ± SE. 50%: 50 percent of peak power output; 60%: 60 
percent of peak power output; 70%: 70 percent of peak power output. *p < 0.05 






































































































































































































































































































































































































































































































































































































































































































































































































































Individual Data  
Due to the heterogeneous nature of MS, clinical and performance decrements 
can be masked when examining group averages. For this reason we have chosen to 
dedicate this next section to presenting a sample of individual data that is representative 
of the MS group averages and an individual that does not follow the trends of the group.  
Electromyography 
The following data is presented as individual data, and not as group means. Due 
to complications with methodology during data collection, a sufficient data set was not 
obtained that allowed for statistical analysis in the manner that was originally intended 
for the EMG data. EMG was collected throughout each of the GXTs on the Vastus 
Medialus and Vastus Lateralus. The RMS sample was obtained for each muscle during 
each stage every 20 seconds (the first 10 secs and last 10 secs were excluded from 
analysis) and graphed against time. The neuromuscular fatigue threshold would be 
determined as the highest power output to that resulted in a non-significant slope 
coefficient for the EMG amplitude.  Figures 12a. and 12b. are examples of the intended 








Power Output Asymmetry  
 The intensities illustrated for each figure indicated the highest intensity 
completed prior to task failure for each cadence condition. Figures 13a, 14a, and 15a 
illustrate an average representation for the MS group for the Self-Selected, High, and 
Low cadences. Figures 13b, 14b, and 15b illustrate individual data for each cadence 
condition. It should be noted that the individual presented possessed an EDSS of 6 
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Figure 13. Percent Contribution during Self-Selected Cadence GXT 
 
50%: 50 percent of peak power output; 60%: 60 percent of peak power output; 70%: 70 
percent of peak power output. 
 
 
50%: 50 percent of peak power output; 60%: 60 percent of peak power output; 70%: 70 
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13a. MS Group Representative 


























13b. MS Individual 
Left Leg Right Leg




Figure 14. Percent Contribution during High Cadence GXT 
 
50%: 50 percent of peak power output; 60%: 60 percent of peak power output. 
 
 

























14a. MS Group Representative 
 
























14b. MS Individual  





Figure 15. Percent Contribution during Low Cadence GXT 
 
 
50%: 50 percent of peak power output; 60%: 60 percent of peak power output. 70%: 70 
percent of peak power output. 80%: 80 percent of peak power output.  
 
 
50%: 50 percent of peak power output; 60%: 60 percent of peak power output. 70%: 70 
percent of peak power output. 80%: 80 percent of peak power output.  
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15a. MS Group Representative 




























15b. MS Individual  
Left Leg Right Leg





 The following paragraphs will discuss in detail the main findings of the study 
and how the results compare or contrast with previous literature. It will conclude with a 
paragraph addressing limitations associated with the study and considerations for future 
research directions.  
Main Findings  
1. No statistically significant differences between groups were present for W @ 
TF, %PPO, and % Asym. across all three cadence conditions (Self-Selected, 
High, and Low).  
2. A statistically significant group effect was present for TTE during GXTs with 
the MS group reaching exhaustion quicker than the Non-MS group.  
3. A statistically significant interaction between group, cadence, and exercise 
intensity was not detected with no main effects present as well.  
4. The % asymmetry score for MVCs was not statistically significant between 
groups.  
5. Performance on 25WT and 6MWT was not statistically different between 
groups.  
6. VO2max, PPO, and Asym. Self-Selected were significantly correlated with 
performance on both the 25WT and 6MT when subjects are pooled.  
7. In the Non-MS group only a significant correlation between PPO and 
performance on the 6MW was present.  
8. In the MS group VO2max, PPO, and Asym. Self-Selected were significantly 




The current study was conducted with the purpose of investigating several facets 
pertaining to bilateral asymmetry in persons with MS. First, we sought to investigate 
whether persons with MS exhibit greater bilateral asymmetry in power production 
contribution during a double leg graded exercise test compared to healthy controls. 
Second, we sought to examine bilateral differences in muscle activation of the vastus 
lateralus and vastus medialus during a double leg cycling GXT. Third, we sought to 
investigate how exercise intensity and cadence selection affect the manifestation of 
bilateral asymmetry in persons with MS during a graded exercise test. Fourth, we 
sought to investigate bilateral asymmetry in isometric strength of the knee extensors.   
We hypothesized that bilateral asymmetry, in regards to power production 
contribution, during a double leg graded exercise test would be significantly greater in 
persons with MS compared to healthy controls. Results from the current study indicate 
that no statistically significant differences in bilateral asymmetry for power production 
contribution during a double leg GXT were present between the MS group and Non-MS 
group; therefore this hypothesis was rejected. We hypothesized that a bilateral 
difference in muscle activation in the vastus lateralis and vastus medialis would be 
present in the MS group during a double leg graded exercise test. Due to complications 
during data collection an appropriate data set to answer this question could not be 
obtained thus this question cannot be fully addressed in the current study. However, 
individual data relating to this question will be discussed later in this chapter. We 
hypothesized that exercise intensity and alterations to cadence would have a significant 
effect on the level of bilateral asymmetry in power production contribution. Results 




statistically significant effect on bilateral asymmetry in power production contribution. 
We hypothesized that persons with MS would exhibit greater bilateral asymmetry in 
isometric strength of the knee extensors. The results of the current study indicate that 
the MS group does not have a statistically significant difference in strength asymmetry 
score for isometric knee extensor strength from the Non-MS group.  
Bilateral Asymmetry  
 Previous literature has shown evidence of bilateral asymmetry in individual’s 
with MS (4-8). More specifically, bilateral asymmetries have been reported in persons 
with MS for VO2max, PPO, and work performed during single leg cycling (4, 5, 8). One 
of the earliest reports of asymmetry is seen in a case study in which White et al. 
observed that during single leg cycling the right limb was able to achieve a PPO of 
170W while the left leg was only able to achieve a PPO of 150W (8). These single leg 
PPOs translated to 85% and 75%, respectively, of double leg PPO resulting in a 10% 
difference in performance between limbs. Larson et al. reported a 17.1W difference 
between limbs during a single leg ramp incremental exercise test indicating a 28.0% 
difference in PPO between the strong and weak legs in the MS group compared to the 
4.3% in the healthy control group (4). A 22.6% difference in VO2peak achieved 
between single leg trails was only observed for the MS group with only a 5% difference 
observed in the healthy control group. Bilateral asymmetry in work performed during 
single leg cycling at a fixed submaximal workload was also observed in an MS cohort 
by Larson et al. (5). Persons with MS had a statistically significant between-leg 
difference for work performed during the single leg trial. This between leg difference 




 To this point all of the previous studies examining asymmetries in lower limb 
performance during cycling in persons with MS have utilized single leg cycling. 
Essentially these previous studies have required individuals to perform a bipedal 
movement in a uniped manner. By completely isolating the limbs during this exercise 
modality, researchers may have altered the natural biomechanics of the cycling 
modality which in part could explain the different findings between the current study 
and previous literature The uniqueness of the current study is that the methodology 
allows for the observation of the interaction of the lower limbs during a bipedal 
movement when bilateral asymmetry may be present. In addition, the current study is 
one of the first to use dual power meter equipment in the study methodology with the 
primary purpose of observing bilateral differences in the contribution of each leg to 
total power production at relative exercise intensities in an MS cohort. The utilization of 
this methodology allows for the current study to be one of the first to observe in an MS 
cohort the limbs performing in a dependent manner with each other rather than 
independently.  
 The current study observed no statistically significant differences in percent 
difference in the contribution to power production between the limbs across three 
relative exercise intensities (50, 60, and 70% of PPO). However, asymmetry ranged 
from 8.41 to17.2% in the MS group with effect sizes ranging from 0.79 to 1.13, 
indicative of a moderate to strong effect. Although not statistically different, a moderate 
to strong effect for asymmetry is present between the groups suggesting that larger 
levels of asymmetry may be present in the MS group. The non-significant findings of 




asymmetry during cycling in persons with MS (4, 5, 8). This discrepancy may be due to 
methodological differences between the current study and previous ones. As mentioned 
earlier, previous studies have utilized single leg cycling while the current study utilized 
double leg cycling (4, 5, 8). Both White et al.  and Larson et al.  assessed bilateral 
asymmetry in a similar manner; both used a ramp GXT protocol and were only able to 
assess bilateral asymmetry at PPO and not submaximal intensities (4, 8). The magnitude 
of asymmetry seen in the current study (range 8.41 to 17.2%) was similar to White et al. 
(10%) but lower than Larson et al. (28%). However, Larson et al. reported an effect size 
of 1.7, indicating a strong effect, for bilateral leg differences in PPO between groups. 
Similar effect sizes are present in both Larson et al. and the current study but with 
differences in significant and non-significant findings suggest that differences in subject 
pools could potentially play a role. It also suggests that similar findings for the presence 
of asymmetry may be present but cannot be detected with the current sample size and 
statistical analysis. 
Differences between the current study and previous literature regarding the 
exercise intensity and exercise intensity domain in which bilateral asymmetry was 
assessed could provide insight into the discrepancies in findings. Exercise intensity and 
the exercise intensity domain in which exercise is performed at has an impact on the 
rate and nature of fatigue development during exercise. The upper limit of the moderate 
exercise intensity domain is indicated by the lactate threshold, and the boundary 
between he heavy and severe exercise intensity domains is indicated by the critical 
power, the highest metabolic rate that can be maintained for an extended period of time. 




recruitment and a disproportionate increase in the rate of neuromuscular fatigue 
development compared to lower exercise intensities (102, 103). This increased rate of 
neuromuscular fatigue development can be linked with reductions in muscle excitability 
due to alterations in plasma potassium [K
+
], which may reflect a rise in interstitial [K
+
] 
within the t-tubule which weakens the propagation of action potentials along the surface 
of the membrane, resulting in a reduced amplitude of the action potentials (104, 105). 
This process attenuates Ca
2+
 release from the sarcoplasmic reticulum, reducing cross-
bridge formation and the force-generating capacity of the myocyte which further 
contributes to fatigue (106).. By assessing differences in power production between 
limbs at PPO, this would have allowed for participants to exercise in the severe exercise 
intensity domain and induce alterations to the excitability of the myocytes. Persons with 
MS already experience weakening or inhibition of action potentials from the central 
nervous system (CNS) through the neuromuscular junction, coupled with the further 
reduction in the propagation of action potential along the myocyte membrane could 
have induced the bilateral asymmetry reported by Larson et al. and White et al. (4, 8, 
88). Assessment of bilateral asymmetry at peak power output was not done in the 
current study due to methodological differences. However, similar findings have been 
found in unpublished pilot data from the current laboratory when examining bilateral 
differences in power output at the gas exchange threshold, critical power, and PPO in 
persons with MS. No significant differences between limbs were present except at PPO.      
Participants in the current study completed an initial GXT to determine VO2max 
and PPO. Subsequent GXTs were individualized in a manner that allowed subjects to 




consisted of a 3 minute warm-up at 25% of PPO and then immediately transitioned into 
3 minute stages at relative exercise intensities from 50 to 100% or their PPO in 
succession. ICCs were conducted for VO2max (MS group: 0.99; Non-MS group: 0.99) 
and max heart rate (MS group: 0.99; Non-MS group: 0.98) obtained from each GXT, 
and indicated a strong reliability between visits for both measures. It was our intention 
to assess bilateral asymmetry from 50 to 100% of PPO. However, we were only able to 
obtain a complete data set for analysis for 50 to 70% of PPO due to subjects reaching 
task failure much earlier than anticipated. Although similar warmup intensities and 
length compared to the current study were utilized in previous literature, differences in 
the increase in work rate and length of test do exist. Larson et al. allotted participants a 
5 minute rest upon completion of the warmup before beginning a ramp protocol 
corresponding to a 1W increase every 2 secs while White et al. started at 100W and 
increased 10W per minute (4, 8). Upon completion of the 70% stage in the current study 
subjects had been exercising continuously for 720 secs while single leg GXTs were 
completed in 147 secs and 113 secs in Larson et al. and 300 and 420 secs in White et al 
(4, 8). Differences in the increase in work-rate between the current study and previous 
ones resulted in drastically different exercise time. The length of the exercise protocol 
begins to plays a factor in the development of fatigue, especially when exercising above 
lactate threshold (LT) (107). Lactate threshold has been reported to occur between 50 
and 65% of VO2max in healthy adults and ~57% in those with MS  (108, 109). We 
speculate that the current methodology required participants to exercise for several 
minutes at or above their lactate threshold, inducing a metabolic response resulting in 
the accumulation of metabolic by products such as lactate and H
+




increase of 5.49 to 7.68 mmol/l in blood [La]. The accumulation of lactate is due to an 
imbalance between its rate of production and its rate of removal. Training status plays a 
large role in the ability to maintain this balance, with those possessing higher levels of 
endurance training demonstrating greater abilities either remove or reduce the 
production of lactate (107). Participants in the current study were considered sedentary, 
indicating lower levels of lactate kinetics. A strong correlation exists between increases 
in lactate concentration and reductions in power output (110). This accumulation of 
lactate coupled with an extended exercise time at or above lactate threshold could 
potentially have induced the development of peripheral fatigue resulting in the 
termination of exercise prior to reaching the severe exercise intensity domain where 
bilateral asymmetry has been demonstrated to occur by previous studies (4, 8).  
Carpes et al. examined the effects exercise intensity had on bilateral asymmetry 
in mean crank torque in trained cyclist (111).  At intensities < 90% of VO2max there 
was a significant difference in peak crank torque between the lower limbs, but above 
>90% VO2max asymmetry decreased to the point of non-statistically significant.. 
However, due to the small sample size of the study (n = 6) the authors suggested using 
an asymmetry index (AI) to detect differences. The AI suggests that any differences 
between limbs greater than 10% are considered asymmetrical. Using this technique the 
results showed that the largest AI between the limbs (25%) was actually at intensities 
>90 of VO2max, while intensities <90% VO2max induced the lowest AI (<10%). 
Additionally Carpes et al. examined mean crank torque asymmetry at intensities 
between 60 and 70% of VO2max and found AI that ranged from 2 to 16% (82). The 




AIs were present. It was highlighted that AI changed systematically with crank torque 
and exercise intensity, and it was suggested that this was due to fatiguing of the 
dominant limb.  
Due to the heterogeneous nature of MS standard statistical analysis may not 
detect the presence of various symptoms, such as bilateral asymmetry, when examining 
them based on group averages. Therefore it may be appropriate to use techniques, such 
as the AI index put forth by Carpes et al., to assess asymmetry in addition to standard 
statistical analysis. During the self-selected cadence condition in the MS group, the AI 
for 50, 60, and 70% were 16.7 ± 17.1%, 13.9 ± 15.3%, and 12.4 ± 12.1% respectively; 
indicating the presence of asymmetry in this group. However, in the Non-MS group the  
AI for the same relative intensities during the self-selected cadence condition did not 
reach levels that would indicate the presence of asymmetry, 6.26 ± 5.37%, 5.21 ± 
4.08%, and 3.63 ± 3.93% respectively. Similar values from the self-selected cadence 
were seen for both groups during the high cadence condition, indicating the presence of 
asymmetry at 50, 60, and 70% in the MS group while no asymmetry was present for the 
Non-MS group. During the low condition an AI of >10% was only present during the 
50% intensity stage for the MS group, while no stages had an AI of >10% in the Non-
MS group. When examining the average asymmetry seen throughout each of the three 
cadence conditions for both groups the MS group had an AI of  > 10% for the self-
selected, high, and low conditions (31.69 ± 51.3%, 23.4 ± 38.9%, and 23.4 ± 38.9% 
respectively) while the Non-MS group’s AI remained at <5% during all three 
conditions. The levels of AI seen in the current study are similar to those seen by 




Previously it has been reported that cadence has a significant impact on levels of 
asymmetry during cycling in trained and non-trained healthy controls. Currently there is 
no conclusive relationship between pedaling rate and asymmetry levels (18, 21, 83). No 
real discernable pattern existed in the current data set as well. We had speculated that by 
increasing the number of muscular contractions an individual was performing at the 
same relative and absolute power output this would require an increase in the 
propagation of action potentials from the central nervous system (CNS) to the 
peripheral musculature. In theory this increase would increase the strain on the CNS 
leading to earlier task failure via neuromuscular fatigue. We had planned on assessing 
this greater rate of development of neuromuscular fatigue via EMG and the RMS 
amplitude. However, we were not able to collect a sufficient sample for analysis. We 
can however comment on the TTE and % of PPO that participants reached during each 
trial. No large differences were of note between all the conditions in the Non-MS group, 
and very little differences existed between the Self-Selected and Low cadence 
conditions for TTE (13 secs) and %PPO (2.2%) in the MS group. When comparing 
these two conditions to the High cadence large differences begin to appear. TTE 
occurred 165 and 152 secs sooner compared to the Self-Selected and Low cadences. 
Participants reached task failure at a power output 10% and 12.2% lower compared to 
the Self-Selected and Low cadence. We can speculate that the High cadence condition 
induced a greater rate of fatigue development in the MS group than the Self-Selected 
and Low cadences. The nature of the fatigue (neuromuscular vs. metabolic) cannot be 




EDSS is an incremental scale used to assess the level of physical disability 
associated with multiple sclerosis (29). Higher EDSS scores are often associated with 
greater disease progression. In order to determine the relationship between EDSS scores 
and the level of asymmetry for contribution to total power output in the lower limbs 
Pearson’s r correlations were ran. A positive significant relationship was found between 
EDSS scores and asymmetry across all, indicating that the higher the disability status 
the higher the levels of asymmetry. This could help explain the lack of significant 
findings in the current study. The average EDSS score in the MS group of the current 
study was 2.0 ± 2.04, indicative of minimal disability. It can be speculated that 
asymmetry may not be detectable or reach significant levels until higher EDSS scores 
are reached.    
Maximal Voluntary Contractions  
 Bilateral asymmetry in isometric knee extensor strength has been observed in 
persons with MS in previous literature with mixed results.  Chung et al. 2005 and 2008 
on both occasions observed no statistically significant differences for peak isometric 
torque and isometric strength asymmetry in the knee extensors (6, 7). Larson et al. 
observed a statistically significant difference in maximal voluntary isometric 
contraction (MVIC) strength of the knee extensors between limbs in the MS group with 
no statistically significant difference between the limbs in the Non-MS group (4). The 
difference between the limbs was also statistically significantly greater in the MS group 
compared to the Non-MS group. The results of the current study are in agreement with 
the findings of Chung et al., and in contrast with those of Larson et al. (4, 6, 7). 




MS group, 20.6 ± 19.8 %, compared to Larson et al., 18.2 ± 9.4 %. The values in the 
Non-MS group, 18.0 ± 4.1 %, of the current study are greater than that reported by 
Larson et al., 11.3 ± 7.9 %. The large amount of asymmetry present in the Non-MS 
group, compared to previous literature, could possibly explain the lack of significant 
findings despite similar asymmetry scores in the MS-group compared to previous 
studies. Differences in statistical analysis could also provide some explanation as well. 
Larson et al. performed analysis on the absolute difference between the limbs after 
classifying the limbs as strong and weak. Whereas the current study utilized asymmetry 
scores which provide a better indication of the magnitude of difference rather than just 
absolute difference. This difference in findings is interesting  as the MVC methodology 
used in the current study mimicked that of Larson et al. (4).  
 As mentioned previously the amount of asymmetry seen in the Non-MS group 
of the current study was larger compared to the Non-MS groups of previous literature 
(4). Limited research has been performed examining strength asymmetry of the lower 
limbs in younger healthy adults that are not trained athletes. Perry et al. 2006 examined 
the relationship between age and lower limb strength asymmetry in the knee and ankle 
extensors. Significantly greater levels of asymmetry in knee extensor asymmetry was 
observed in the older group (76.4  ± 0.8 yrs) compared to the younger group (29.3 ± 0.6 
years). However, the amount of asymmetry observed by Perry et al. (8 to 14%) was still 
less than that observed in the current study. Due to the lack of research in this area 
further investigation would be beneficial for identifying the amount of lower limb 




Functional Performance Tests  
 Both the 25WT and 6MWT are common functional performance tests 
administered when evaluating persons with MS (13, 39, 77). The 25WT is a part of the 
Multiple Sclerosis Functional Composite Score, and has been shown to be a good 
measure of overall walking ability in clinical populations (91). The 6MWT has been 
shown to be a good indicator of muscle and walking endurance in persons with MS, and 
is considered to be a good indicator of the exercise level of activities of daily living   
Lower performance on functional performance tests such as the 25WT and 6MWT in 
persons with MS compared to those without has been observed in previous literature 
(91, 112, 113). However, the results of the current study are in contrast with the results 
of previous studies. The current study found no statistically significant difference in 
performance on both the 25WT and 6MWT between the MS group and Non-MS group. 
Again, the potential differences found in the current study compared to the previous 
literature could be related to the average level of disability in the cohort in the current 
study. The average EDSS in the current study was reported to be 2.0 ± 2.4, this 
indicates a minimal level of disability. This suggests that the current cohort’s disease 
progression may not have a severe impact on physical function.   
Relationship between Walking Performance and Physiological Variables  
 Pearson’s correlation coefficients were examined to assess the relationship 
between isometric strength asymmetry, VO2max, PPO, Asym. Self-Selected, and 
performance on the 25WT and 6MWT. We examined these relationships first by 
pooling all subjects together to increase the sample size and reduce type II error. In the 




Asym. Self-Selected (r = 0.91) were significantly correlated with performance on 
25WT. Additionally, VO2max (r = 0.76), PPO (r = 0.79), and Asym. Self-Selected (r =-
0.76) were significantly correlated with performance on 6MWT. These relationships 
indicate that individuals with a higher VO2max and PPO require less time to walk 25 
feet and can walk a greater distance in 6 minutes. The relationship between Asym. Self-
Selected indicate that those persons with larger amounts of asymmetry require more 
time to cover 25 feet and cover less distance during 6 minutes of walking. To our 
knowledge this is one of the first studies to examine the relationship between levels of 
asymmetry during double leg cycling and functional performance measures, indicating 
that higher levels of asymmetry have a negative impact on walking performance.  
 To investigate if the MS group exhibited correlations between the physiological 
variables and the functional performance tests, Pearson’s correlations were examined in 
each group independently. The results indicated that significant correlations in the MS 
group existed between VO2max (r = -0.75), PPO (-0.82), Asym. Self-Selected (r = 
0.91), and performance during the 25WT. In contrast the Non-MS group did not exhibit 
any significant correlations between the physiological variables and 25WT 
performance. The correlations seen in the MS group reflect a similar finding in the 
pooled data, such that individuals with a higher VO2max and PPO required less time to 
walk 25 feet and those with larger amounts of asymmetry require more time to walk 25 
feet.  
 The MS group also exhibited significant correlations between VO2max (r = 
0.87), PPO (0.87), Asym. Self-Selected (r = -0.82), and distance covered during the 




and distance covered during the 6MWT. These relationships in the MS group are again 
similar to those seen in the pooled subjects, such that persons with higher a VO2max 
and PPO are able to walk a greater distance over 6 minutes and those with larger 
amounts of asymmetry.  
An interesting finding from the current study was the absence of a significant 
relationship between knee extensor strength asymmetry and performance on the 25WT 
and 6MWT. Previously strength asymmetry in knee extensors as well as the knee 
flexors has been shown to be strongly correlated to walking ability in MS patients (7, 
114, 115). The previous literature reported statistically significant differences between 
isometric strength asymmetry of the knee extensors between person with MS and 
without. However, the current study did not observe this difference, and potentially 
could explain the differences seen in the relationship between walking performance and 
isometric strength asymmetry. As reported earlier the average EDSS scores for the 
current study indicated a minimal level of disability suggesting little to no impact on 
walking capabilities.   
Electromyography during Cycling  
 Although we were not able to perform our intended analysis for the EMG data, 
alternative analysis was conducted. We examined the average RMS amplitude for each 
exercise intensity and expressed it as a percentage of the maximal RMS amplitude. No 
significant differences were observed between the limbs and conditions. However, due 
to the small viable sample size an increased risk for type II error is present. We 
observed very high RMS amplitudes (60 to 75%) at the lowest exercise intensity (50% 




intensity stage was in the high cadence condition. Starting at such a high percentage of 
maximal RMS amplitude may potentially provide some explanation for the quicker 
termination of exercise during this condition. We can speculate that the higher number 
of muscular contractions may have put a larger strain on the CNS, especially when 
comparing at the 50% stage, potentially leading to a greater rate of development of 
neuromuscular fatigue. However, when examining the slope coefficients between 
exercise intensities within each condition no significant differences were present. 
Again, due to the small viable sample size for this analysis the risk of type II error is 
increased. 
Determination of the Presence of Bilateral Asymmetry in MS  
 Bilateral asymmetry is still an emerging topic in MS research. Although bilateral 
asymmetry in cycling performance and MVC strength has been observed in previous 
literature, the current study did not find a statistically significant difference in 
asymmetry levels for cycling performance and MVC strength between an MS group and 
Non-MS group (4, 5, 8). Upon further examination, similar effect sizes for asymmetry 
levels in cycling performance and MVC strength were observed in the current study 
compared to previous literature (4). When using alternative analysis methods, such as 
the 10% AI, for the average asymmetry during each cadence condition significant levels 
of asymmetry were present in the MS group for both the Self-Selected and High 
cadence conditions while the Non-MS group did not show significant asymmetry levels 
for any cadence conditions. In fact, 6 participants from the MS group had an average 
asymmetry greater than 10% during the Self-Selected cadence condition. Seven had 




cadence condition. The MS group displayed asymmetry levels two to three times that of 
the Non-MS group across all cadence conditions. We believe that the current study 
highlights the limitations of using traditional statistical analysis when researching a 
disease with a very heterogeneous nature, such as MS. We believe that in order to 
properly assess the presence of some symptoms, such as bilateral asymmetry, additional 
analysis such as effect sizes or thresholds should be used for the use of determining 
meaningful and clinical significance to allow for analysis on an individual and group 
basis. This not a ground breaking notion as the AI index of 10% has been used in 
previous literature for assessing asymmetry during cycling in trained and untrained 
individuals (17, 20, 22, 111). A recent study with MS chose to focus on effect size 
estimates, rather than statistical significance, as an approach for identifying meaningful 
differences between groups (116). The same group adopted a benchmark of 0.5 standard 
deviation as an indication of meaningful difference between groups (116, 117). We 
believe that these additional methods for the determination of significance have an 
appropriate application for an MS cohort.  




   






CHAPTER V: CONCLUSIONS  
The bilateral asymmetry in the contribution of each limb to the total power 
output during double leg cycling was assessed at 50, 60, and 70% of PPO and across 
three distinct cadence conditions (Self-Selected, High, and Low) in a sample of MS and 
Non-MS participants to determine if a significant difference between the two groups, 
the three intensities, and three cadence conditions existed. Significant differences in 
asymmetry were not observed between groups, intensities, and conditions. However, 
using the suggested 10% AI methodology for determining asymmetry during cycling, 
asymmetry was present in the MS group at the 50, 60, and 70% intensities for both the 
Self-Selected and High condition and the 50% intensity in Low condition. An AI of 
>10% was not observed at any intensities or conditions in the Non-MS group. MVCs 
were conducted to assess strength asymmetry in the knee extensors, and no significant 
differences existed between the MS group and Non-MS group. The current study is one 
of the first to explore the relationship between bilateral asymmetry during double leg 
cycling and walking performance. It was observed that bilateral asymmetry during 
double leg cycling has a negative impact on walking performance.  
Answer to Research Questions  
First Research Question  
Do persons with MS exhibit greater bilateral asymmetry in power production 
contribution during a double leg graded exercise test compared to healthy 
controls? It was hypothesized that individuals with MS would exhibit greater 
bilateral differences in power output during a double leg cycling graded exercise 




between the MS group and Non-MS group in asymmetry in contribution to total power 
production between the lower limbs. Our hypothesis was not supported by our data and 
was rejected.  
Second Research Question  
Is there a bilateral difference in muscle activation during double leg cycling in 
persons with MS? It was hypothesized that a bilateral difference in muscle 
activation during double leg cycling in persons with MS would exist. Due to 
complications during data collection an sufficient sample size to adequately address this 
question was not obtained. Thus this question cannot be fully addressed currently.  
Third Research Question  
Does exercise intensity and cadence selection affect the physical manifestation of 
bilateral asymmetry in persons with MS? We hypothesized that the manipulation 
of exercise intensity and cadence would have a significant effect on the physical 
manifestation of bilateral asymmetry. We did not observe a significant difference 
between the MS group and Non-MS group in asymmetry between conditions and 
intensities. Our hypothesis was not supported by our data and was rejected.  
Fourth Research Question  
Do persons with MS exhibit greater bilateral asymmetry in isometric 
strength of the knee extensors compared to healthy controls? We hypothesized 
that persons with MS would exhibit greater bilateral asymmetry in isometric 
strength of the knee extensors compared to healthy controls? We did not observe 




asymmetry in the knee extensors. Our hypothesis was not supported by our data and 
was rejected.  
Clinical Significance  
 Bilateral asymmetry has been reported previously in persons with MS, and these 
asymmetries have a significant impact in their daily life. Often impairments in 
functional capacity prevents individuals with MS from being able to perform activities 
of daily living and participating in regular exercise leading to an elevated risk of the 
development of comorbidities. One area that remained unclear was the impact of 
exercise intensity on the physical manifestation of bilateral asymmetry in persons with 
MS. More specifically, whether or not exercising at submaximal intensities induced 
large amounts of bilateral asymmetry in the lower limbs. The results of this study 
suggest that exercise intensity does not impact the manifestation of bilateral asymmetry 
as similar levels of asymmetry were seen between submaximal intensities in the MS 
group, and were not statistically significantly different from the Non-MS group. This 
could potentially provide justification for the prescription of exercise at various 
submaximal intensities in persons with MS, as it will not increase asymmetry and 
potentially increase risk for falls. An important finding of the current study was the 
strong negative relationship between bilateral asymmetry in contribution to total power 
production during double leg cycling and performance in both the 25WT and 6MWT. If 
a person with MS is exhibiting decrements in walking performance, a potential solution 
could be to prescribe an exercise training protocol with the aim to reduce bilateral 
asymmetry in the lower limbs. Although the current study did not observe any 




using an asymmetry index it was determined that large amounts of asymmetry were 
present in the MS group compared to the Non-MS group. This observation highlights a 
common issue that occurs when researching diseases that are heterogeneous in nature. 
Often the presence of an effect or symptom can be masked when examining group 
means, but when alternative methods are used that allow for observations to be 
performed on a group and individual level it can be detected. A need for a better form of 
analysis to detect effects or symptoms is needed for researching persons with MS. The 
evaluation of asymmetry highlights a facet of physiological performance that cannot be 
detected when simply assessing walking capacity or VO2max. The assessment of 
asymmetry identifies muscular imbalances that potentially identifies individuals with 
fall risk, but also provides insight for proper exercise prescription. By evaluating 
asymmetry, practitioners can prescribe specific exercise modalities with the aim of 
reducing asymmetry.        
Future Directions  
  Both the results and unforeseen issues during data collection with the current 
study provide insight and direction for future research. We speculate that reasons for 
differences in the findings of bilateral asymmetry during cycling in the current study 
compared to the previous literature may pertain to methodological differences. Previous 
studies have assessed bilateral asymmetry in power production only at PPO and during 
single leg cycling. The current study aimed to assess bilateral asymmetry from 50% to 
100% of PPO, but the cumulative fatigue of the protocol potentially induced the earlier 
task failure in the current study that prohibited being able to examine asymmetry at 




allow for several minutes of rest after 3 minute trails at various exercise intensities to 
inhibit the development of peripheral fatigue due to the accumulation of metabolites 
such as lactate and H
+
. This will allow for the examination of bilateral asymmetry 
across all exercise intensities and domains. The current MS sample possessed a low 
EDSS score that corresponds to minimal levels of disability. This more than likely 
impacted the results of the current study. Future research with bilateral asymmetry 
would benefit from recruiting individuals that have higher levels of disability.   
Limitations  
As with any study the limitations associated with the current study need to be 
addressed. First of all, due to a rather small sample size some of the comparisons made 
were underpowered and additional significant differences may have been observed if 
more participants had been enrolled. This does not mean those results are any less 
meaningful as many had large effect sizes. Also, the results are only representative of 
those who completed the study, who were 23 to 61 years of age and had a diagnosis of 
relapse-remitting MS. Another limitation to the current study was the ability to only 
observe bilateral asymmetry at submaximal intensities and not being able to assess at 
higher intensities like previous studies. Fatigue is always a limitation when studying 
persons with MS. However, fatigue was controlled to the best of our ability using tow 
common fatigue questionnaires. The current study assessed bilateral asymmetry during 
cycling rather than during walking due to availability of equipment and safety concerns. 
Both cycling and walking are bipedal movements that involve the limbs working in a 




relative exercise intensities without the fear of falling. Ideally, asymmetry would have 
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Appendix B: Modified Fatigue Impact Scale, Health History 
Questionnaire, and Kurtzke Questionnaire  
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